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ABSTRACT

RELATIVE SENSITIVITY TO CHANGE OF PSYCHOTHERAPY OUTCOME
MEASURES FOR CHILDREN AND ADOLESCENTS: A COMPARISON
USING PARENT- AND SELF-REPORT VERSIONS OF THE
CBCL/6-18, BASC-2, AND Y-OQ-2.01

Debra Theobald McClendon
Department of Psychology
Doctor of Philosophy

This repeated-measures study evaluated the relative sensitivity to change of the
Child Behavior Checklist/6-18 (CBCL/6-18), the Behavior Assessment System for
Children-2 (BASC-2), and the Youth Outcome Questionnaire-2.01 (Y-OQ-2.01).
Participants were recruited from Valley Mental Health, a community outpatient clinic in
Salt Lake City, UT. There were 178 participants for 136 cases, with 134 adults and 44
adolescents. Participants provided two through five data points for a total of 548 data
points. Hierarchical Linear Modeling (HLM) was conducted for three major
comparisons: adult informants, adult and adolescent dyads, and adolescents. Results
indicated the Y-OQ-2.01 was the most change sensitive, while the BASC-2 and CBCL/618 were not statistically different from each other. Results also showed that the parentreport measures were more change-sensitive than the self-report measures completed by

adolescent informants. Sensitivity to change was also evaluated through the reliable
change index (RCI) and the use of cut-off scores. In comparisons using the RCI, the YOQ-2.01 identified the most cases for reliable change. The Y-OQ-2.01 also had the
greatest corroboration of its findings with the other two measures. In comparisons using
cut-off scores, results are offered for three variations, as different standards were used to
establish cut-off scores for the three measures. The third variation, for which cut-off
scores for all three measures were adjusted to one standard deviation above the mean, is
suggested to be the most appropriate when comparing measures. Those results indicated
there was no statistical difference in how the measures performed relative to each other.
Thus, based on the HLM and RCI results of this study, it is recommended that clinicians
select the Y-OQ-2.01 for outcome use and tracking changes in child and adolescent
symptoms and behaviors. Keywords: treatment outcome, child, adolescent, sensitivity to
change.
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-1Relative Sensitivity to Change of Psychotherapy Outcome Measures for Children and
Adolescents: A comparison using parent- and self-report versions of the CBCL/6-18,
BASC-2, and Y-OQ-2.01

CHAPTER 1
Introduction
Outcome measures are increasingly used in all health care fields due to managed
health care organizations. These organizations have been set up to provide quality care at
minimal cost (Richardson & Austad, 1991). To accomplish this objective health care
organizations demand accountability by health care professionals; they must demonstrate
that the care they provide is beneficial to their patients. Clinical psychology, along with
all mental health care professions, is subject to this demand as well. If practitioners in the
mental health field desire to participate in treating clients that use these health care
corporations to manage the access they have to services, then they must adapt clinical,
administrative, and organizational procedures to meet the health care organizations’
expectations (Richardson & Austad, 1991). Therefore, in recent years there has been a
stronger focus on outcome assessment within clinical psychology; practitioners are
increasingly required to demonstrate the efficacy of the treatment they provide (Koss &
Shiang, 1994).
Many measures used for treatment outcome have been adopted as outcome
instruments although they were initially designed for some other purpose, such as
assigning an accurate diagnosis. Two such measures with widespread use in clinical child
and adolescent psychology include the Child Behavior Checklist (CBCL; Achenbach,

-21991) and the Behavioral Assessment System for Children (BASC; Reynolds &
Kamphaus, 1992). In spite of their widespread use, these measures may not be valid for
assessing outcome (Lambert & Hill, 1994). An outcome measure is intended to measure
change due to a psychotherapeutic intervention. Although these adopted measures
generally have excellent psychometric properties, they have unknown or restricted
sensitivity to change because they tend to assess static constructs that take longer to show
change (Berrett, 2000; Vermeersch et al., 2000). Yet, sensitivity to change is the most
important characteristic of an outcome measure (Burlingame et al., 1995). The Outcome
Questionnaire (Lambert et al., 1996) was specifically designed to track treatment
progress and outcome in adults while the Youth Outcome Questionnaire (Y-OQ;
Burlingame et al., 2001) is a similar measure specifically for child and adolescent
populations. The Y-OQ was developed to address the shortcomings of other measures in
child and adolescent research and clinical practice by allowing assessment of dynamic
constructs that would be sensitive to behavioral and symptomatic changes when
administered on a regular basis.
Using measures without established change sensitivity, such as the CBCL/6-18
and the BASC-2, is potentially problematic since their consumers attempt to assess the
quality of treatments and calibrate the needs of individual clients based on the data these
measures produce. Since it is not clear how these measures compare to those specifically
designed to assess therapeutic outcome, such as the Y-OQ-2.01, a comparative study was
necessary to evaluate their relative sensitivity to change. Significant differences found
between these measures regarding sensitivity to change will allow the work of
researchers, clinicians, and health care corporations to be maximized for the ultimate

-3benefit of clients by discontinuing the use of measures that are not as sensitive to change
in favor of measures that would meet their purposes for assessment more appropriately.
While no significant differences found between these measures will allow outcome
measure consumers to select a measure based on other desired attributes, such as its
ability to diagnose.
Therefore, the purpose of this study was to investigate the relative sensitivity to
change of the Youth Outcome Questionnaire (Y-OQ-2.01) and two measures often used
for outcome assessment that were not designed for that purpose, the Child Behavior
Checklist (CBCL/6-18) and the Behavior Assessment for Children (BASC-2).
Discussion of this research and its findings proceeds as follows:
Chapter 2 contains an exploration of the literature in regards to the purpose of
outcome measures and their importance to researchers, clinicians, and health care
corporations. It also examines measuring outcome, including the psychometric
considerations of reliability, validity, and sensitivity to change; the discussion focuses on
sensitivity to change. The specific characteristics of the CBCL/6-18, BASC-2, and YOQ-2.0 are then discussed, followed by a comparison of all three measures with regard to
recommendations made by researchers and clinicians, as reported in the literature, on key
features of outcome measures. Finally, chapter 2 presents the statement of the problem, a
review of the analysis of therapeutic change, and the hypotheses of the present study.
Chapter 3 discusses the methods of this study including a description of the clinic
used for data collection, response rate, demographic features of the sample, and logistical
procedures used. This chapter also discusses how reliable change indices were calculated
to determine those participants whose data would be retained for analysis and presents a

-4summary of their demographics. Attention then turns to a literature review of
Hierarchical Linear Modeling, the chosen analytic procedure.
Chapter 4 presents the results of this study. It reviews descriptive results from the
reliable change index (RCI) and cut-off score comparisons. It also reviews the HLM
analyses that include comparisons for adult informants, adult and adolescent dyads, and
adolescent informants.
Chapter 5 discusses the major findings of this study along with their implications
for researchers and clinicians working with children and adolescents. It also addresses
limitations of this study while making recommendations for future studies.
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Literature Review
Purpose of Outcome Measures
Within the mental health community, using outcome measures has become
increasingly important in recent years to researchers, clinicians, and health care
corporations (Burlingame, Lambert, Reisinger, Neff, & Mosier, 1995; Burlingame et al.,
2001; Burlingame, Wells, Lambert, & Cox, 2004).
Researchers
Standardized outcome assessment is a fundamental component of psychotherapy
research (Ogles, Lambert, & Fields, 2002). Although research has well documented the
effectiveness of psychotherapy with adult populations (Lambert & Ogles, 2004), the
parallel research with children and adolescents is less well-developed (Kazdin, 1993).
Nevertheless, research in this area suggests that psychotherapy for children and
adolescents is effective (Kazdin, 1993) and that individual therapy with children is
approximately as effective as with adults (Brown, 1987). Advances continue in this area,
with studies examining the effectiveness of therapy for children and adolescents
exceeding 1,500, including over 500 modes of treatment (Kazdin, 2004). However,
according to Kazdin (2004), most of these treatments have never been subjected to
empirical research. As empirical inquiry proceeds, Kazdin (1995) recommends that
standardized outcome measures be used to profile children and adolescents in a consistent
way to further researchers’ efforts by allowing them to integrate studies about specific
problems. Durlak et al. (1995) also indicate that the use of outcome measures would
strengthen the child psychotherapy research.

-6Clinicians
Clinicians are theoretically the fundamental consumers of psychotherapy research
so they can implement effective research developments into their treatments (Burlingame
et al. 2004). However, clinicians are often suspicious of the research process. For many,
the research process seems dissimilar from clinical practice and even appears irrelevant
(Burlingame et al., 2004). Often, research topics and individuals used as subjects within
the research are so different from what clinicians work with on a daily basis that
generalizability to clinical practice is limited (Kazdin, 1991). Another reason for the
discrepancy between clinicians and researchers is that third-party payers do not view the
research findings as irrelevant; instead, they rely on these findings. Many clinicians fear
losing their jobs or positions on provider panels if they do not make substantial gains in
brief time frames with more severely disturbed clients than the researchers ever attempted
to treat in their studies (Brown, Burlingame, Lambert, Jones, & Vaccaro, 2001).
However, Durlak et al. (1995) reviewed the literature on clinicians’ concerns and found
that, in spite of clinicians’ suspicions, research findings are applicable to clinical practice.
One of the most helpful contributions researchers have made to clinicians is the
development of various outcome measures; however, many clinicians have not yet
adopted the use of these instruments in their clinical practice. Recently, Hatfield and
Ogles (2004) discovered that, out of 874 randomly selected practicing psychologists, only
37% used some form of outcome assessment in their practice. When those who did not
use outcome measures (n=550) were asked their reasons for not doing so, they indicated,
in order of importance: “adds too much paperwork”, “takes too much time”, “extra
burden on clients”, “feel it is not helpful”, and “do not have enough resources.”

-7Yet despite these negative perceptions, there are indications of a trend toward
increased outcome measure use among clinicians in general (Phelps, Eisman, & Kohout,
1998). Although Hatfield and Ogles (2004) reported 37% of practicing psychologists in
their study use outcome measures, it is a substantial increase over the 29% reported by
Phelps et al. (1998) and the 23% reported by Bickman et al. (2000). Furthermore, it is
important to note that of those clinicians in the Hatfield and Ogles (2004) study who
reported using outcome measures, the proportion of child and adolescent clinicians using
outcome measures actually was higher (54%).
This trend of increased outcome measure use may be due in part to the advantages
they provide to the clinician as they provide psychotherapy treatment to their clients.
Both researchers (Lambert et al., 2001; Wells, Burlingame, Lambert, Hoag, & Hope,
1996) and clinicians in the Hatfield and Ogles (2004) study come together in agreement
regarding these advantages:
1. Outcome measures serve as an intake measure of current functioning, initial
severity, and an index of risk factors that might moderate expectations for
rapid improvement (Lambert et al., 2001; Wells et al., 1996).
2. Outcome measures track change—the progress that has been obtained since
therapy started (Lambert et al., 2001; Wells et al., 1996). “Tracking client
progress” was the most important reason stated among clinicians who used
outcome measures. In addition, it was also rated as the most useful type of
information that outcome measures produce among those clinicians who did
not use outcome measures (Hatfield & Ogles, 2004).

-83. Using standardized outcome measures can provide additional outside
validation of clinical judgment, which can aid practitioners in providing better
services for their clients. “Determine if there is a need to alter treatment” was
the second most important reason stated among clinicians using outcome
measures (Hatfield & Ogles, 2004).
4. Outcome measures provide a potential summary source for demonstrating the
effectiveness of therapeutic interventions (Wells et al., 1996) by the use of
aggregated data. Through analysis of data from their own clientele, clinicians
can make decisions about the effectiveness of their own delivery of
psychotherapeutic services (Hatfield & Ogles, 2004; Lambert, Hansen, &
Finch, 2001).
5. The use of outcome measures represents a more ethical practice (Clement,
1994). “Ethical practice” was the third reason given by psychologists for using
outcome measures (Hatfield & Ogles, 2004).
The trend may also be due in part to private insurance companies and managed
care companies increasingly requiring practitioners to administer outcome-assessment
instruments in order to make decisions for insurers and care managers about the
effectiveness and efficiency of services. These external pressures may influence the
degree to which clinicians use outcome measures, regardless of whether clinicians would
choose to use them of their own accord (Hatfield & Ogles, 2004). However, in the
Hatfield and Ogles (2004) study, “Required by MCO/insurance” (MCO=managed care
organization) and “Required by work setting” were not central for clinicians who used
outcome measures (i.e. they were indicated as the 5th and 6th most important reasons).
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Health Care Corporations
The cost of providing mental health treatment to children and adolescents is
difficult to estimate. However, evidence from several sources indicates a concern for
cost-containment and accountability in the health care market (Burlingame et al., 1995).
Between the years of 1986 and 1996, expenditures for mental health services grew at an
average annual rate of more than 7 percent, which was equivalent to the growth seen in
total health care costs during the 1990s (U.S. Dept of Health and Human Services, 1999).
According to Burlingame et al. (2004), managed health care systems and the so-called
era of accountability are the health care industry’s response to these increasing costs.
Therefore, in spite of the concerns of clinicians described previously, third-party payers
require providers to be able to document therapeutic progress. “How much therapeutic
effect can be ‘bought’ for how much therapy?” is the central question for which these
companies are searching for answers (Linden & Wen, 1990). This zeitgeist has put
psychotherapy outcome research into a central role as researchers are pressured to
provide health care corporations with valid, reliable, and sensitive measures to track the
quality of mental health treatment.
Health care corporations enter data from standardized outcome measures into a
data bank for analysis. According to Wells et al. (1996) this allows health care
corporations to report therapeutic effectiveness to subscriber companies and profile
individual providers; establish decision algorithms to empirically determine appropriate
session limits (e.g., expectancy tables); and answer further research questions, such as
evaluating the efficacy of new treatment modalities (Wells et al., 1996).
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corporations have intersected, theoretically and practically. A critical method for
addressing these needs is to measure treatment outcome.
Measuring Outcome
Many outcome measures used by clinicians have little or no empirical foundation
(Froyd, Lambert, & Froyd, 1996). Employing outcome measures that have demonstrated
acceptable reliability and validity estimates and are sensitive to change is crucial in order
to accurately and reliably assess change as it occurs during and after therapy (Lambert &
Hill, 1994; Wells et al., 1996). This practice will allow clinicians to provide the best
possible services to their clients (Hatfield & Ogles, 2004).
Reliability
The reliability of a measure is important since it is an estimate of the amount of
error contained therein (Allen & Yen, 1979). If estimated reliability is low, a clinician’s
confidence regarding the measure’s ability to accurately reflect changes in an individual’s
symptoms and behavior is also low due to the presence of greater amounts of error. If
estimated reliability is high, then a clinician’s confidence in the measure’s ability to
reflect changes in an individual’s symptoms and behavior is also high due to the presence
of limited amounts of error. High estimated reliability also indicates that, if an individual
is given a measure a second time (or repeatedly), similar results would be found if that
individual remained stable on the symptoms and behaviors the measure was designed to
assess.
In outcome measurement estimated reliability serves an additional function. The
measure is often given to individuals before and after treatment and/or several times
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measurements. The change score reflects both the true difference in the symptoms and
behaviors being measured and the error inherent within the measure (Allen & Yen, 1979;
Lambert & Hill, 1994). Thus, reliability of the change scores will be directly affected by
the estimated reliability of the outcome measure. An outcome measure with low
estimated reliability will produce measurements that will vary over time and across
studies due to the higher level of error within the measure; these measurements may lead
to mixed findings regarding the effectiveness of a given treatment. As the purpose of an
outcome measure is to assess the effectiveness of a given treatment by way of measuring
changes in an individual’s symptoms and behavior, an outcome measure with low
reliability cannot be used to accurately measure change and will prove uninformative to
clinicians.
Researchers (Burlingame et al., 1995; Durlak et al., 1995) recommend internalconsistency reliability-coefficients, which estimate the homogeneity of items on a
measure, at or above 0.80. Test-retest reliability assesses the temporal stability of an
outcome measure, usually by administering an instrument to subjects twice, without a
significant variable introduced in the intervening time period. Researchers (Durlak et al.,
1995; Reisinger & Burlingame, 1997) recommend that this statistic be above 0.70.
Validity
The validity of a measure is also important to the study of outcome sensitivity
since it is concerned with the measure’s ability to measure what it purports to measure
(Reisinger & Burlingame, 1997). This general definition of validity is actually a
description of construct validity: how well a given instrument measures a theoretical
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outcome measure for use in clinical practice. Face validity refers to the measure’s
appearance of validity, content validity the adequacy with which the measure’s items
assess the construct domain, and criterion-related validity the measure’s ability to
correlate highly with other measures designed for a similar purpose or purporting to
measure similar symptoms and behavior. Researchers (Burlingame et al., 1995;
Reisinger & Burlingame, 1997) suggest that validity coefficients be no lower than 0.50
for an outcome measure and consider a validity coefficient above 0.75 to be excellent.
Validity for change. An outcome measure is intended to measure change in
symptoms and behavior following psychotherapeutic treatment. Some outcome measures
were specifically designed to track treatment progress, including outcome; others have
been adopted as such although they were previously designed for some other purpose,
such as assigning an accurate diagnosis. Regardless of developmental origin, it is still
vital to the validity of the measure for use in outcome measurement to be able to detect
change. “Validity alone is not sufficient to make a measure responsive to treatment
effects. What is required is validity for change. A measure can be a valid indicator of a
characteristic but still not be a valid indicator of change on that characteristic” (Lipsey,
1990, p. 100). If a measure demonstrates acceptable construct, face, content, and
criterion-related validity, and yet is limited in its ability to detect change when change
has occurred, then the validity of the instrument for use as an outcome measure is
compromised. For example, a measure designed to provide diagnostic profiles is not
clearly useful in assessing outcome (Lambert & Hill, 1994), although it may be clearly
useful in aiding clinicians to assign appropriate diagnoses.

- 13 Lipsey (1990) gives guidance on evaluating a measure’s validity for change.
When identifying experimental studies in which the treatments, samples, and measures
are similar to those one might have planned to conduct, if those studies show large
effects, this indicates that the measures must have validity for measuring change. Effect
size is represented by d and is a measure of the degree to which the population means of
two samples differ (µ1-µ0) in terms of the standard deviation of the parent population
(Howell, 2002). More specifically, d for any outcome measure is the difference between
post-treatment means for treatment and comparison groups divided by the outcome
measure’s standard deviation. According to Cohen (1988), an effect size is considered
small when d = 0.20, moderate when d = 0.50, and large when d = 0.80 or greater.
Validity for change has not been clearly discussed in the child and adolescent
outcome literature; perhaps it has been considered synonymous to sensitivity to change.
For example, Burlingame et al. (2001) noted that an early study showing large effect
sizes for the CBCL (Webster-Stratton, 1984) “provide[d] evidence for the measure’s
overall sensitivity to change” but then noted that the “CBCL’s sensitivity to change
resulting from psychotherapy has been questioned” (Drotar, Stein, & Perrin, 1995, p.
363). It appears that the Webster-Stratton (1984) article provided evidence not for
sensitivity to change in a general or “overall” sense, but evidence of validity for change.
Sensitivity to change is much more complex and more difficult to achieve than validity
for change.
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To understand sensitivity to change, it is first important to understand the concept
of sensitivity as used in the psychometric literature. Sensitivity deals with the issue of
inclusion—how well an instrument selects subjects for the trait it is measuring.
Sensitivity is calculated by dividing the number of true positives identified by the
measure by the total number of actual positives (which includes those missed by the
measure). Values range from 0 to 1.0 and the higher the value, the more sensitive the
measure. Sensitivity has a reciprocal relationship to specificity. Specificity deals with
the issue of exclusion—how well an instrument deselects a subject for the trait it is
measuring. Specificity is calculated by dividing the number of true negatives identified
by the measure by the total number of actual negatives (which includes those missed by
the measure). Values range from 0 to 1.0 and the higher the value, the more specific the
measure. Sensitivity and specificity are largely determined by the set-point for the cut-off
score of the measure (Allen & Yen, 1979).
When sensitivity is expanded to repeated-measures or multi-wave data, where
change scores are of interest, it becomes the new but related issue of sensitivity to
change. It is identified by examining subjects of varying severity levels via sensitivity
and specificity analyses (Burlingame et al., 2001). Sensitivity to change is also examined
by identifying the clinical significance associated with cut-off scores and a reliable
change index (RCI; Jacobson et al., 1984; Jacobson & Truax, 1991). The assumption of
using a cut-off score is that a client’s outcome score will drop from a clinical range to a
normal range following successful psychotherapeutic treatment. This score is a set-point
that serves to define a client’s score relative to either the clinical or normal populations

- 15 (Burlingame et al. 2001). The RCI is unique to each outcome measure and establishes a
confidence-interval based on error variance that must be exceeded in order to label a
client’s change as “reliable” (Burlingame et al., 2005). The goal of the RCI is to allow an
outcome measure to identify when a client has made changes as a result of the therapeutic
intervention.
Sensitivity to change is important when assessing the value of an outcome
instrument, since it reflects a measure’s ability to detect changes that occur as a result of
participation in psychotherapeutic treatment (Lambert & Hill, 1994). This can also be
considered equivalent to the measure’s responsiveness (Vermeersch, Lambert, &
Burlingame, 2000). Lipsey (1990) defined sensitivity more precisely: “Measurement
sensitivity…means that measured values fully reflect any change of interest on the
characteristic measured and do not reflect an appreciable amount of…variance from any
other source” (Lipsey, 1990 p. 120).
These definitions suggest that an outcome measure’s sensitivity to change is
directly related to the ability of the instrument to do what it purports to do, which is to
measure an individual’s change in symptoms and behavior over time due to a
psychotherapeutic intervention. Therefore, the concept of sensitivity to change is best
conceptualized as an issue of construct validity (Vermeersch et al., 2000).
Criteria for establishing sensitivity to change. According to Kazdin (2005),
evidenced-based assessment requires “delineating the different purposes of assessment,
and then, for each purpose, identifying the special requirements and then the criteria for
stating when these requirements are met” (p. 548). Reliability, validity, and sensitivity to
change have each been discussed in terms of their importance to outcome measures,
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important characteristic of a treatment outcome instrument” (underlines included in
original source). Outcome measures are qualitatively different from other measures, such
as those used to make diagnostic decisions that do not need to be sensitive to change.
Given the importance of change sensitivity for psychotherapy outcome measures,
researchers have begun to propose criteria for establishing change sensitivity that are
disparate from criteria used to establish psychometrics for other measures (Guyatt, 1988;
Meier, 1997).
Three criteria have been suggested when selecting items for measures that assess
change:
1. Items should show change resulting from an intervention (Tryon, 1991) and
overall change reflected in client scores on a given item must occur in the
theoretically proposed direction (Vermeersch et al., 2000). Although a client
may worsen on an item during the initial stages of therapy, resulting in
changes in item scores opposite to those proposed, the overall change
reflected in an item must occur in the theoretically proposed direction
2. Items should not change when there is no intervention, such as when the client
is placed in control conditions (Tryon, 1991). More specifically, since several
studies have identified the presence of re-test effects that result in decreased
endorsement of symptomatology over time by clients who go untreated
(Aneshensel, Estrada, Hansell, & Clark, 1987; Durham, Burlingame, &
Lambert, 1998; Jorm, Duncan-Jones, & Scott, 1989), clients receiving an
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conditions (Vermeersch et al., 2000).
3. Changes in scores should not be attributable to measurement error or to
confounding factors such as social desirability, practice effects, mechanical
responding, or mere regression (Vermeersch et al., 2000).
Limits to sensitivity. There are reliable differences in the sensitivity to change of
outcome measures (Casey & Berman, 1985). Information regarding an outcome
measure’s sensitivity to change is needed before the instrument can be confidently used
to evaluate the effects of treatment on individuals (Deyo & Inui, 1984; Lipsey, 1983).
Although this information may not always be readily available, Vermeersch et al. (2000)
identify five limits to a measure’s ability to be change-sensitive that may help researchers
and clinicians evaluate a measure of interest:
1. Scales within the measure may include items that are not relevant to the
construct of interest. This is largely related to the use of multi-trait scales
(Fitzpatrick et al., 1992).
2. Measures eliciting responses that are categorically arranged (e.g., yes–no or
true–false) or restricted to a small range (e.g., a Likert-scale range from 0 to
2) may be scaled in units that are too gross to detect or be sensitive to change
(Lipsey, 1990).
3. Scales may contain instructions to the respondents that are not conducive to
the detection of change. For example, outcome measures that ask clients to
answer items according to how they have felt over an extended period of time
(e.g., over the past 6 months) are not likely to be sensitive in detecting
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brief period of time (Berrett, 2000).
4. Instruments may include items that tap into constructs that are more static and
therefore less susceptible to change; while others may include items that tap
into constructs that are more dynamic and therefore more susceptible to
change. Measures that tap into static constructs may have greater difficulty
detecting client changes within brief periods.
5. Measures may contain items that are subject to floor or ceiling effects. This is
problematic because it can limit the ability of the item to detect growth or
depreciation at the upper or lower end of the construct of interest (Lipsey,
1990).
Sensitivity to change relative to measures’ varying forms. Many measures have
different forms that vary based on the informant from whom the data are obtained. The
most commonly used forms for children and adolescents are parent-, teacher-, and selfreport. Although it would be expected that these different forms would have varying
levels of sensitivity to change, this feature has yet to be discussed in the literature. Drotar
et al. (1995) discussed the relative sensitivity of the CBCL’s parent form to the teacher
and self-report forms for screening purposes (identifying disorders) and found the CBCL
parent-form to be the most sensitive. However, this type of sensitivity cannot be
considered synonymous with change sensitivity. In an epidemiological study that
examined parent–child/adolescent dyad data on a generic measure of health and wellbeing, the Child Health Questionnaire, Waters, Stewart-Brown, and Fitzpatrick (2003)
reported that adolescents are more sensitive to their general health, body pain, mental

- 19 health than are their parents. Although these content areas are included in most outcome
measures, this finding should not be inferred to mean that children and adolescents would
be more sensitive to documenting change in these areas due to a psychotherapeutic
intervention. Finally, Casey and Berman (1985) reviewed 75 studies and found that
different measures did report the effects of treatment differently; observers, therapists,
parents, and subject performance reports produced significantly higher effects than
teacher- and child self-report. This finding may indicate that parent-report forms would
be more sensitive to change than a child or adolescent’s self-report form, but since it is
reported in terms of treatment effects it is unclear if similar conclusions would be made
regarding sensitivity to change.
Recommendations for Properties of Outcome Measures
To aid clinicians, researchers, and health care managers in choosing an ideal
outcome instrument, the following recommendations from researchers and clinicians
have been identified from the literature:
1. An outcome measure should have excellent reliability (Lambert & Hill, 1994;
Vermillion & Pfeiffer, 1993; Weber, 1997).
2. An outcome measure should have excellent validity (Lambert & Hill, 1994;
Vermillion & Pfeiffer, 1993; Weber, 1997); including validity for change
(Lipsey, 1990).
3. An outcome measure should contains items that are sensitive to symptomatic
and behavioral changes that occur with treatment (i.e., items are sensitive to
change; Achenbach & Rescorla, 2004; Lambert & Hill, 1994; Vermillion &
Pfeiffer, 1993).
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of the clinical significance of treatment effects, as opposed to only statistical
significance (Durlak et al., 1995; Vermillion & Pfeiffer, 1993); this would
best be accomplished by the use of cut-off scores and an RCI (Jacobson et al.,
1984; Jacobson & Truax, 1991).
5. An outcome measure should be completed by clients in a matter of minutes;
(Burlingame et al., 1995; Kazdin, 2005; Lambert & Hill, 1994; Lipsey, 1990)
so it does not take too much time or put extra burden on clients (Hatfield &
Ogles, 2004).
6. An outcome measure should be scorable and interpretable in a matter of
minutes (Burlingame et al., 1995; Kazdin, 2005; Lambert & Hill, 1994) so it
does not add too much paperwork or otherwise tax the available human
resources (Hatfield & Ogles, 2004).
7. An outcome measure should provide relevant information regarding the client
and changes in her or his symptoms and behavior (Lambert & Hill, 1994) so it
is practical (Kazdin, 2005; Vermillion & Pfeiffer, 1993) and helpful to the
clinician (Hatfield & Ogles, 2004). Lambert et al. (2001) found that giving
feedback to clinicians concerning client change (as assessed by an outcome
measure) resulted in better therapeutic outcome and more therapy sessions for
clients who were at a high risk for treatment failure.
8. An outcome measure should allow frequent use to track progress, or monitor
treatment (Burlingame et al., 1995; Hatfield & Ogles, 2004; Kazdin, 2005) so
that treatment can be altered accordingly or problem areas can be identified
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treatment before making an assessment. Much of the research on therapeutic
change has been based on data on a client’s status at two time points, for
example, scores on a pretest and a posttest (Bryk & Raudenbush, 1987). In
general, two time points provide an inadequate basis for studying change
(Bryk & Weisberg, 1977; Rogosa, Brandt, & Zimowski, 1982).
9. An outcome measure should be cost efficient (i.e., inexpensive) so it does not
adversely impact the consumer’s financial resources (Burlingame et al., 1995;
Hatfield & Ogles, 2004; Weber 1997).
The Child Behavior Checklist/6-18 (CBCL/6-18)
The CBCL/6-18 is the newest version of the CBCL, the most commonly used
child and adolescent measure used in the assessment of psychosocial dysfunction
(Kazdin, 1994); it is probably the most commonly used measure for outcome purposes as
well (Hatfield & Ogles, 2004). The CBCL/6-18 is only one of a family of measures
called the Achenbach System of Empirically Based Assessment (ASEBA; Achenbach &
Rescorla, 2004) that was developed for assessing problems, competencies, and adaptive
functioning for people of all ages. This system also includes the Child Behavior
Checklist for Ages 1 ½-5 (CBCL/1 ½-5), Caregiver-Teacher Report Form for Ages 1 ½-5
(C-TRF), Teacher’s Report Form (TRF), the Youth Self-Report (YSR), the Direct
Observation Form (DOF), the Semi-structured Clinical Interview for Children and
Adolescents (SCICA), and the Test Observation Form (TOF).
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According to Achenbach, the developer of the CBCL, “It was the lack of
satisfactory constructs and operational definitions for childhood disorders that prompted
us to develop the CBCL in order to assess parents’ perceptions of their children’s
competencies and problems” (1991, p. 83). Achenbach (1991) reported that
competencies can be as important as problems for understanding children and
adolescent’s adaptive development. Therefore, researchers developed the CBCL
following a two-stage process that addressed both the competencies and the problems of
children and adolescents.
The first stage of the CBCL’s development involved a literature review of the
assessment of competence in order to obtain candidate items and then pilot tested
descriptions of positive characteristics in various formats. Prior to this development, there
was little research to confirm which competencies reportable by parents discriminated
between those children who were adapting and those children who were identified as
needing help for behavioral or emotional problems (Achenbach, 1991).
The second stage of the CBCL’s development was to develop the procedures for
assessing child and adolescent behavioral and emotional problems. Researchers began by
obtaining descriptions of problems that concerned parents and mental health
professionals. These descriptions were obtained from earlier research, reviews of the
clinical and research literature, and consultation with clinical and developmental
psychologists, child psychiatrists, and psychiatric social workers. The CBCL problem
section was pilot tested and revised through a series of nine editions completed by parents
of children seen in a variety of settings from 1970 to 1976. Parents’ ratings were then
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empirically-based syndromes were used to construct scales by which to establish
statistical norms.
Using the CBCL/6-18
The CBCL/6-18 is filled out by a child or adolescent’s parent or other significant
adult figure. In filling out the CBCL/6-18 competencies portion, an adult is asked to rate
the child or adolescent on how well or how often, as compared to other children or
adolescents of the same age, he or she engages in: sports, hobbies, organizations,
chores/jobs, friends, family relationships, and academics.
For the problems portion of the CBCL/6-18, a parent is asked to rate the child or
adolescent on 118 problems that may be observed in their child or adolescent presently or
within the last six months. The ratings are on a 3-point Likert scale (0 = Not true, as far
as you know; 1 = Somewhat or sometimes true; 2 = Very true or Often true). The threestep response scale was chosen because, according to Achenbach (1991), it is usually
easier to fill out than a present/absent scale for untrained raters such as parents and “more
finely differentiated response scales were rejected because fine gradations in problems
are unlikely to be captured by a questionnaire” (p. 14). Achenbach further stated that
scoring problem items on more differentiated scales became vulnerable to respondent
characteristics, and which reduced the discriminative power of items below that obtained
with the three-step scales (Achenbach, Howell, Quay, & Conners, 1991). Furthermore,
those scales did not increase differentiation of syndromes derived from ratings of
behavioral or emotional problems (Achenbach & Edelbrock, 1978). Some items, in
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problem to provide potentially valuable information to the clinician.
The CBCL/6-18 usually takes 15-17 minutes to complete. The Youth Self Report
(YSR) is utilized by 11- to 18-year olds to report their own competencies and problems.
It has many items in common with the CBCL/6-18 but is tailored specifically to the child
or adolescent acting as her or his own informant. The CBCL/6-18 is self-administered, so
it does not take any clinician time for administration, and scoring is most frequently
accomplished quickly by computer. Forms cost 60 cents each; there is no per-use charge
for scoring or administration by computer software
(http://www3.parinc.com/products/product.aspx?Productid=CBCL-S). The purchase
price for the computer scoring software is $345. Also, a Web-Link makes the need for
supplies of forms obsolete (Achenbach & Rescorla, 2004).
Content Domains
The CBCL/6-18 competencies section is scored on the following scales:
Activities, Social, School, and Total Competencies. The Total Competencies is the sum
of the other three scales. The CBCL/6-18 problems section contains two major headings:
Internalizing and Externalizing. Internalizing problems are identified as:
Anxious/Depressed, Withdrawn/Depressed, and Somatic Complaints syndromes.
According to Achenbach and Rescorla (2004), these primarily reflect problems within the
self. Externalizing problems are identified as: Aggressive Behavior and Rule-Breaking
syndromes, which the authors indicate as primarily reflecting conflicts with other people
and with social mores. Those scales not included under the internalizing and
externalizing rubrics are Social problems, Thought problems, Attention problems and
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they identify items of particular clinical concern. The CBCL/6-18 also has
diagnostically-oriented scales that are designed to discriminate between people referred
for mental health services and those who have not been referred for such services:
Affective Problems, Anxiety Problems, Somatic Problems, Attention
Deficit/Hyperactivity Problems, Oppositional Defiant Problems and Conduct Problems.
The Total Problems score is the sum of all the problem scales and is the most global
index of psychopathology on the CBCL/6-18 (Achenbach & Rescorla, 2004).
Psychometric Properties
Reliability. Internal consistency estimates for the CBCL using a test/re-test
interval of seven days produced a mean correlation of 0.87 for all of the competence
scales, while the mean for the total competence scale is 0.87. The mean of all of the
problem scales is 0.89, while the total problems scale mean is 0.93 (Achenbach, 1991).
When using test/re-test assessments obtained over an 8- to 16-day interval, internal
reliability estimates of all the CBCL scale scores are 0.90 (Achenbach & Rescorla, 2004).
These high estimates of internal consistency indicate that the CBCL/6-18 is a reliable
measure.
Validity. Content validity of the CBCL is supported by the numerous
competencies and problems it assesses that are of clinical concern to parents and mental
health workers. Construct validity of the CBCL is supported by the correlations of its
scales with analogous scales on the Quay-Peterson (1983) Revised Behavior Problem
Checklist and Conners’ (1973) Parent Questionnaire. Criterion-related validity is
supported by the ability of the CBCL to predict membership in a clinical (inpatient and
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borderline group is allowed, the accuracy of classification increases to 89.1%
(Achenbach, 1991). More recent research (Burlingame et al., 2001) has found varying
levels, indicating the CBCL will correctly identify members of clinical population 75%
of the time and members of a normal population 87% of the time. Validity estimates
range from 0.59-0.86 (Achenbach, 1991).
The CBCL appears valid for change. It has been used successfully as an outcome
measure in hundreds of studies. See for examples: (Crawford, Field, Fisher, Kaplan, &
Kolb, 2004; Larson, 1998; Packman, 2002; Seligman, Ollendick, Langley, & Baldacci,
2004; Webster-Stratton, 1984). Effect sizes in these studies are within the large and
moderate ranges.
Cut-off scores. The CBCL makes good use of T-scores. A separate cutoff Tscore exists for each scale: the competence scales, the syndrome scales, the internalizing
and externalizing scales, and the total problem scale. In each case there is a borderline
clinical range below the cut-off which separates the normal and clinical ranges. For the
competence scales, T-scores below the borderline range are within the clinical range,
while all scores above it are within the normal range. For all other scales, T-scores below
the borderline range are within the normal range, while T-scores above it are in the
clinical range (Achenbach, 1991). This difference in scoring is due to normal subjects
having greater numbers of competencies while having fewer problems. The CBCL does
not have a raw cut-off score in order to clearly ascertain a client’s status by simply
summing item scores, yet on the Total Problems scale T-scores of 60-63 are classified as
borderline and scores of 64 and above are classified as clinically significant.

- 27 Reliable change index. In the appendix of each ASEBA manual the authors have
provided information by which clinicians can assess the quality of change they observe
on the scale scores of the ASEBA instruments. This information includes the standard
error of measurement (SEM) for each scale separately for samples of referred and nonreferred children and adolescents of each age and gender, as well as by each type of
informant from which the data were obtained. If the change in scale score exceeds one
SEM, then the change observed exceeds that which would be expected by chance 68% of
the time. If clinicians desire a 95% confidence interval, then they can simply multiply
the SEM by 1.96.
Although the authors indicate that Jacobson and Truax (1991) have suggested the
use of the RCI as a statistical basis for documenting changes from pre- to post-treatment
assessments, it does not appear that they have calculated this statistic for the CBCL. A
study performed by Behrens and Satterfield (2006) used the Jacobson and Truax method
for evaluating RCI with the CBCL/6-18, and they indicated that it defined a range of two
standard deviations using raw score points (they did not use T-scores), 21 points on the
CBCL/6-18, and 29 points on the YSR.
Use as an Outcome Measure
The CBCL has been used to provide broad measures of change after treatment in
clinical research designs. By 1999, there were already over 300 publications reporting
treatment research using the ASEBA instruments (Newman, Ciarlo, & Carpenter, 1999).
The CBCL can also be used in evaluating outcomes for individual children. It can
be used to track treatment progress, as well as providing pre- and post-assessment
outcomes. To monitor treatment for individual children and adolescents the authors
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as every 3 months” (Achenbach & Rescorla, 2004 p. 203). If clinicians choose to
administer the CBCL more frequently than the 6 months recommended in the standard
instructions, the authors indicate the rating interval used in considering the first
administration should also be shortened in order to maintain even intervals. However, in
1991, Achenbach recommended allowing at least 2 months between assessments, both to
minimize possible “practice effects” and to allow time for “behavioral changes to occur
and become apparent to raters” (p. 74). Achenbach (1991) also indicated: “Because of
the time required for behavioral change to stabilize and become clearly recognized by
parents, rating periods of less than 2 months are probably not worth using” (p. 228).
More recently, Achenbach and Rescorla (2004) altered this time-frame, indicating that
the CBCL should “probably not be readministered at intervals of less than about 1
month” (p. 203). The aspects of functioning it measures take time to change (i.e., it
measures static, rather than dynamic, variables). Moreover, as previously noted for the
recommended 2-month interval, time is needed for changes to stabilize and for
informants to become aware of the changes.
The results of these repeated administrations can be used to track functioning in
relation to scale score norms for the child or adolescent’s age, gender, and type of
informant (if using other forms). The data provided by the CBCL allows clinicians to see
actual change in scale scores and whether scores have moved from the clinical range to
the borderline or normal range (Achenbach, 1991; Achenbach & Rescorla, 2004).
Sensitivity to change. The CBCL suggested cut-off of 60 has a sensitivity index
of 0.754 and a specificity of 0.870 (Burlingame et al., 2001); this means it will correctly
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or normal range 87% of the time.
The child and adolescent clinical research literature on outcome measures
includes statements regarding the CBCL’s sensitivity to change resulting from
psychotherapy. The CBCL is a traditional measure that was originally designed to
measure relatively stable dimensions, not to measure therapeutic change (Berrett, 2000).
Without evidence of sensitivity to change, the use of traditional measures, such as the
CBCL, to assess psychotherapeutic change may be inappropriate, as their lack of
sensitivity to change often prohibits the measure from demonstrating therapeutic change,
even when significant change has occurred (Berrett, 2000). Drotar et al. (1995) have
discussed the limited sensitivity to change of the CBCL, yet it is still commonly
employed as an outcome measure in child and adolescent therapy research and its authors
advocate its use as such (Achenbach & Rescorla, 2004).
For Drotar et al. (1995), the main concern with the CBCL’s sensitivity to change
is its restricted ability to accurately measure ratings below the clinical level. Clinicians
anticipate their treatments will facilitate a child or adolescent’s change from the clinical
level to the sub-clinical, or normal, level. If an assessment is done once the adolescent
has dropped below the clinical level (i.e., has only mild symptoms), the CBCL may no
longer provide “sensitivity for detecting variation” (Drotar et al., 1995, p. 185).
Therefore, Drotar et al. (1995) give the following recommendation:
Researchers should be cautious about making inferences based on scores from the
CBCL and related instruments that are within the normal range. Investigators
who are interested in detection of more subtle adjustment problems or assessment

- 30 of psychological competence may wish to consider additional or alternative
instruments that have been designed specifically for this purpose. (p. 190)
Several aspects of the CBCL’s design may contribute to concern about its
sensitivity to change. The CBCL contains a Likert scale ranging from 0 to 2, as
discussed previously. A relatively narrow range for responding, such as this, may not be
sensitive to changes that take place in a child or adolescent’s functioning (Lipsey, 1990).
Additionally, the instructions in the CBCL instruct the parent to answer each item based
on the child’s behavior now or in the past six months. Since psychotherapeutic
treatments in today’s managed care era tend to be brief, with many clients only receiving
4-20 sessions, changes that occur as a result of therapy may not be reflected in the results
since parents are completing the CBCL in relation to the past six months, encompassing
all of the child or adolescent’s time in therapy as well as pre-therapy functioning (Berrett,
2000). This problem can produce possible confusion that can confound the results.
There are also concerns about how scoring may influence the CBCL’s sensitivity.
Subjective scoring for items requiring open-ended descriptions and suppression of Tscores for clients in the non-clinical range (i.e., all raw scores below the 69th percentile
are assigned the same T-score) further inhibit the measure’s sensitivity to distinctions
between those with mild symptoms who are in the sub-clinical range (Drotar et al., 1995).
Achenbach (1991) suggested using raw scale scores in statistical analyses rather than Tscores to address the problem of suppression for those in the non-clinical range, because
the raw scores reflect all differences among individuals. However, this method reduces
the ability make comparisons across age and sex groupings (Achenbach, 1991) and does
not solve the problem of how to interpret the differences that are observed (Drotar et al.,
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(2001) indicates that social competence (i.e., school failure, special education,
relationship with parent, physical or mental disabilities) is the only domain covered by
the CBCL that is relevant to outcome (Mosier, 2001).
The Behavior Assessment System for Children-2 (BASC-2)
The BASC-2 (Reynolds & Kamphaus, 2004) is a recent revision of the Behavior
Assessment System for Children (Reynolds & Kamphaus, 1992). The BASC-2 was
designed to “facilitate the differential diagnosis and educational classification of a variety
of emotional and behavioral disorders of children and to aid in the design of treatment
plans” (Reynolds & Kamphaus, 2004, p. 1). The BASC-2 is a multi-method system for
ages 2-21; its components may be used individually or in any combination. It contains a
Self-report of Personality (SRP); Parent Rating Scale (PRS); Teacher Rating Scale
(TRS); Structured Developmental History (SDH); and Student Observation System
(SOS).
Development
The development of the original BASC involved several stages. The
conceptualization of the measurement system was based on a comprehensive review of
behavior-rating and self-report instruments, a goal to assess both adaptive and
maladaptive behaviors, and consultations with child and adolescent clinicians (Reynolds
& Kamphaus, 2004). Item content came through consultations with teachers, parents,
and children; psychologists; and reference sources, such as the Diagnostic Statistical
Manual. Once item content was established, there were two item tryouts in 1986 and
1987 involving teachers, parents, and children from Kentucky, Nevada, Texas, Georgia,
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(Reynolds & Kamphaus, 1992).
Standardization of the BASC was accomplished by selecting a much larger
general sample that was representative of the United States through the regions of
Southwest, South, North Central, and Northeast. The sample sizes included thousands of
teachers, parents, and children (Merenda, 1996). Statistical analysis consisted of item-toscale correlations as well as confirmatory factor analysis (Reynolds & Kamphaus, 2004).
The first step in creating the BASC-2 was to make a comprehensive review of the
original BASC with the goal of increasing the consistency of item content between the
TRS and the PRS across age levels for each form (Reynolds & Kamphaus, 2004). Some
items that had previously been omitted for a particular age group were re-included. Also,
items that appeared only on the TRS of the original BASC but were deemed reasonable
for both school and home settings were added to the PRS and vice versa. New items
were also written for all BASC scales, with particular attention to those scales with
reliabilities that were not as high as the authors desired. Finally, several new scales were
created to broaden the content domains and allow closer comparisons between forms.
Using the BASC-2
The BASC-2-PRS is completed by a child or adolescent’s parent or other
significant adult figure. The other forms (SRP and TRS) are filled out by the child and
their teacher, respectively. An adult is asked to read phrases that describe how children
may act and then rate their child’s behavior in the last several months relative to the
phrase. The questions are based on a four-point Likert scale. The four-choice response
format uses letters instead of the standard numbers. Parents are asked to circle N for
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behaviors they have observed. The BASC-2-PRS has three versions with varying
numbers of items for different age groups (Preschool, 134 items; Child, 160 items;
Adolescent, 150 items) and takes approximately 10-20 minutes to complete. The TRS is
similar to the PRS, although it usually requires 10-15 minutes to complete. The SRP
form asks children and adolescents to describe their emotional-responses and selfperceptions. The question format consists of true/false questions and the four-point
Likert scale as described for the PRS and TRS. The SRP is slightly longer but has three
forms that vary by age: ages 6-11, 139 items; ages 12-21, 176 items; and ages 18-25, 185
items. The SRP takes approximately 30 minutes to complete.
In hand scoring the BASC, the letter responses of N, S, O, and A correspond to
the scores 0, 1, 2, and 3 points, respectively, while scoring via computer the letters
correspond to 1, 2, 3, and 4, respectively. The BASC system is self-administered so it
does not take any clinician time for administration, and scoring is most frequently
accomplished quickly by computer (Reynolds & Kamphaus, 2004); this takes
approximately 5 minutes (Gladman & Lancaster, 2003). The BASC system also has
hand-scored forms that have a built-in scoring system that is revealed when the clinician
separates the two parts of the carbonized form to reveal an inner page with the items
already scored; calculating the scale and composite scores by hand follows easily but can
be time intensive (Gladman & Lancaster, 2003). The hand-scored forms cost $1.34 each,
while the computer scored non-scannable forms are $1.12 each; the computer scored
scannable forms are $1.76 each
(http://ags.pearsonassessments.com/Group.asp?nGroupInfoID=a30000). A variety of
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appropriate for their needs. For example, the BASC ASSIST software to score nonscannable forms costs $259.00, while the version used to score scannable forms costs
$605.00.
Content Domains
The BASC-2-PRS includes the following scales: Activities of Daily Living,
Adaptability, Aggression, Anxiety, Attention Problems, Atypicality, Conduct Problems,
Depression, Functional Communication, Hyperactivity, Leadership, Learning Problems,
Social Skills, Somatization, Study Skills, and Withdrawal. The TRS and PRS overlap,
but each also possesses unique aspects geared toward the specific informant. These
scales are used to form the following composite scales: Externalizing problems,
Internalizing problems, Adaptive Skills, and Behavioral Symptoms Index (Reynolds &
Kamphaus, 1992, 2005).
Psychometric Properties
Reliability. Internal consistency estimates for the BASC-2-PRS using a test/retest interval of 9-70 days produced mean correlations from 0.78-0.92 for the composite
scales across all three age groups. Reliability of the BASC-2-PRS composite scales is
estimated to be very high, ranging from the low to middle 0.90s using coefficient alpha.
These reliability estimates are quite consistent between females and males, between
clinical and non-clinical groups, and at different age levels (Reynolds & Kamphaus,
2004). These high estimates of internal consistency indicate that the BASC-2 is a reliable
measure. Median inter-rater reliabilities are slightly lower at 0.74, 0.69, and 0.77 for
preschool, child, and adolescent levels respectively, although this is not unexpected
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The BASC-SRP reliability also was high.
Validity. Content validity of the BASC is supported by the numerous
competencies and problems it assesses that are of clinical concern to parents, mental
health workers, teachers, and children. Construct validity of the BASC-PRS is supported
by the correlations of its scales with analogous scales on Child Behavior Checklist
(Achenbach, 1991) and with externalizing scales of the Conners’ Parent Rating Scales
(Conners, 1989). The Minnesota Multiphasic Personality Inventory (Hathaway &
McKinley, 1943 [renewed 1970]), Achenbach’s Youth Self-Report (Achenbach, 1985),
and the Behavior Rating Profile (Brown & Hammill, 1983) showed a number of high
correlations with the BASC-SRP scales. Criterion-related validity is indicated by the
authors (Reynolds & Kamphaus, 2004), although an average classification accuracy is
not presented. Validity is also supported by scale inter-correlations and factor analysis for
the grouping of scales into composites. Validity estimates for the BASC-2 do not appear
to be presented by the authors in the manual (Reynolds & Kamphaus, 2004).
The original BASC appears valid for change. It has been used successfully as an
outcome measure in hundreds of studies (see for examples, Evans, Axelrod, & Langberg,
2004; Lehner-Dua, 2002; Packman, 2002). Effect sizes in these studies are within the
large range, with some subscale effect sizes falling within the moderate range, and a few
subscales falling in the small range. Although the BASC-2 is new, it is expected that it,
too, is valid for change as its psychometric properties are improved from those of the
original BASC.
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representative of the general population with regard to age, gender, ethnicity, and clinical
or special education classification (Reynolds & Kamphaus, 1992, 2004). Normative
scores are provided for each scale of the BASC including a T-score and a percentile.
Notably, the BASC makes use of Linear T-scores, so it is not appropriate to interpret
these T-scores in terms of the normal distribution. The T-scores must be interpreted in
light of their corresponding percentiles because the relationship with linear T-scores and
percentiles varies with the shape of the score distribution (Reynolds & Kamphaus, 2004).
The BASC does not have a raw cut-off score in order to clearly ascertain a client’s status
by simply summing item scores, yet T-scores of 60-69 are classified as at-risk and scores
of 70 and above are classified as clinically significant.
Reliable change index. The BASC-2 does not make use of the RCI in order to
allow clinicians to easily evaluate the reliability of change in their clients’ symptoms and
behavior.
Use as an Outcome Measure
The results of repeated administrations of the BASC can be used to track
functioning in relation to scale-score norms for the child or adolescent’s age, gender, and
type of informant (if using other forms). The data provided by the BASC allows
clinicians to see actual change in scale scores and whether scores have moved from the
clinical range to normal range.
Although the original BASC had some limitations for use in outcome assessment
because it did not contain enough items to assess changes in the patterns of illicit
substance abuse or other severe behavior problems (Kamphaus, Reynolds, Hatcher, &
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However, outcome studies with this newer version are as yet unavailable.
Sensitivity to change. There are no published data on sensitivity to change for the
BASC or BASC-2. There have been several explorations of the BASC’s sensitivity in
assigning diagnoses (Doyle, Ostrander, Skare, Crosby, & August, 1997; Ostrander,
Weinfurt, Yarnold, & August, 1998), but this type of sensitivity cannot be considered
synonymous with the measure’s sensitivity in assessing changes due to a
psychotherapeutic intervention.
The Youth Outcome Questionnaire-2.01 (Y-OQ-2.01)
The Youth Outcome Questionnaire (Y-OQ-2.01) is one of a family of measures
that has been developed by researchers at Brigham Young University in collaboration
with several managed care organizations that oversee health care throughout the Western
United States. The Y-OQ-2.01 is a measure that assesses child and adolescent client
improvement after a therapeutic intervention. The OQ family of instruments also
includes measures to track adult outcome [OQ-45.2 (Lambert & Burlingame, 1993), OQ30.1, and OQ 10.2]; several screening tools for primary care settings (OQ-PCM and YOQ-PCM), and a prognostic tool (Y-OQ-PA). There is a self-report version (Y-OQ SR2.0) as well as several shorter versions of the Y-OQ (Y-OQ-30.1 and Y-OQ-12) that are
currently under development.
The Y-OQ-2.01 was originally designed as the child and adolescent equivalent to
the OQ-45.2 (Lambert et al., 1996). It was constructed specifically to track treatment
progress (track actual change in client functioning), as opposed to assigning diagnoses,
guiding treatment planning, or other such purposes (Burlingame et al., 2004).

- 38 Development
Lipsey (1990) has noted: “The importance of having valid, reliable and sensitive
dependent measures in treatment effectiveness research is so great that it will generally
warrant considerable advance preparation” (Lipsey, 1990, p. 103). Reisinger and
Burlingame (1997) further indicated that, since sensitivity to change is a relatively new
concept to psychometrics, many older instruments were not designed or evaluated with
that feature in mind. Whereas the CBCL and BASC were carefully designed to assess the
areas of problems and competencies and then later adopted for use in outcome
measurement, the Y-OQ was envisioned to be an outcome measure from its inception,
and this vision guided its development.
The Y-OQ was specifically developed as a response to the health care industry’s
demands for measuring outcome in mental health treatment; to serve as a quality
indicator for managed care providers, third-party payers, and accrediting agencies; and as
an instrument individual clinicians could use to track patient progress. The authors of the
Y-OQ (Burlingame et al., 1996; Wells et al., 1996) have stated that it was specifically
constructed to assess the occurrence of observed behavior change, to be brief, to be
sensitive to change over short periods of time, and to be used on a session-to-session
basis while being available at a nominal cost and maintaining high psychometric
standards of reliability and validity.
The development of the Y-OQ followed a multi-stage process in order to meet the
above-stated criteria. Y-OQ researchers (Burlingame et al., 1996; Wells et al., 1996) first
performed literature searches of narrative and meta-analytic reviews regarding child
clinical treatments in order to identify content domains that had been shown to be
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which the average treated client demonstrated improvement of one-half a standard
deviation were included for scale development. Second, two types of focus groups were
conducted: the first was with children and adolescents, who had been treated in outpatient
and inpatient settings of a managed health care organization, and their parents; the second
was with psychiatrists, clinical psychologists, social workers, and other support staff from
inpatient and outpatient settings. The inpatient provider focus group resulted in a Critical
Items subscale; items these providers suggested were sensitive to change occurring
during the average inpatient hospitalization. In the third stage of the Y-OQ development,
researchers examined 100 treatment charts from inpatient and outpatient sites to identify
recorded treatment-related change related to stated therapeutic goals.
Using the Y-OQ-2.01
The Y-OQ-2.01 is a 64-item instrument designed to measure the level of current
distress a child or adolescent (age 4-17) is experiencing. Parents rate items on a five-point
Likert scale (0=Never or Almost Never to 4=Almost Always or Always). Scores range
from -16 to 240 (negative Y-OQ scores are possible because items that assess adaptive
behavior are reverse-scored and can yield negative numbers). The self-report version (YOQ SR-2.0) is for adolescents 12-18 and is formatted in like manner. The Y-OQ-2.01
takes approximately 5-7 minutes to complete and is scored with use of computer scoring
software; it can also be scored quickly by hand. The Y-OQ-2.01 can be purchased with a
one-time nominal licensing cost as opposed to a fee-per-administration basis. This fee
varies, based on the size of the group obtaining the license. A private-practice clinician
can obtain the license for a price of $75, while a small group of clinicians pays $250
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licensing fee. Once this license is obtained users are not required to purchase forms but
are allowed to photocopy the measure for their use as agreed upon within the license.
Content Domains
Six content subscales were included in the Y-OQ-2.01 based on the results of the
multi-stage developmental process. These subscales tap diverse areas of behavioral
difficulties as well as elements of healthy behavior: Intrapersonal Distress, Somatic,
Interpersonal Relations, Social Problems, Behavioral Dysfunction, and Critical Items.
The total score on the Y-OQ-2.01 is the summation of items from each subscale and is
designed to reflect the total amount of distress a child or adolescent is experiencing. The
total score is the best index to track a client’s global change and has the highest estimated
reliability and validity compared to the reliability and validity of the individual subscales
(Wells et al., 1996).
Psychometric Properties
Reliability. Internal consistency estimates of the Y-OQ-2.01 subscales based on
normative samples range from 0.74-0.93, while the total score estimate is 0.97. This total
score estimate suggests the measure assesses a strong single factor, which is useful for
clinicians since this is the score typically used in order to track client change (Wells et al.,
1996). Also, internal consistency reliability estimates were calculated for each of the
normative samples (Burlingame et al, 2004). In these samples, the Y-OQ-2.01 total score
demonstrated high internal consistency estimates of 0.94 across all normative sample
settings (Burlingame et al., 2001). Additionally, Gironda (2000) calculated an internal
consistency estimate for the total Y-OQ-2.01 score of 0.95.
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average total scores from community normal, outpatient, and inpatient samples.
Community normal participants had the lowest scores and inpatient clients had the
highest scores, while the outpatient sample’s mean score fell between the other two.
Also, the Y-OQ is able to predict membership in a clinical (inpatient and outpatient) or
normal population with an average classification accuracy of 85 percent (Burlingame et
al., 1996; Wells et al., 1996) based on total means using traditional cut-off scores.
Criterion-related validity is supported by high correlations between the Y-OQ total and
subscale scores and other measures used frequently for outcome, such as the Child
Behavior Checklist (Achenbach, 1991) and the Conners’ Rating Scale (Conners, 1990).
The Y-OQ appears valid for change (see for examples, Clark, 2002; Crawford et
al., 2004). Effect sizes in these studies are within the large range. The Clark (2002)
study, which examined the effects of wilderness therapy for adolescents, revealed that,
while each of the scales from the Million Adolescent Clinical Inventory (MACI; Millon,
Millon & Davis, 1993) produced no effect size to moderate effects sizes (0.02-0.75), the
total score of the Y-OQ-2.01 produced a large effect size of 1.87.
Cut-off scores. The Y-OQ-2.01 makes use of a cut-off score. To identify whether
a child or adolescent is within the clinical or normal range, a score of 46 distinguishes the
cut-off. All scores above the cut-off are in the clinical range, while all scores below the
cut-off are in the sub-clinical or normal range (Wells et al., 1996). The cut-off score for
the Y-OQ SR-2.0 is 47 (Wells, Burlingame, & Rose, 2003).
Reliable change index. To evaluate change in scores between administrations of
the Y-OQ-2.01, the developers have calculated an RCI value of 13 points. Therefore, a
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reliable (Burlingame et al., 1996). If the RCI is greater than 13 points, the probability is
less than .05 that the mean difference between the subject’s scores occurred by chance
(Mosier, 2001). RCIs have also been calculated for each of the subscales. The Y-OQ
SR-2.0 has an RCI value of 18 points (Wells et al., 2003).
Use as an Outcome Measure
The Y-OQ was developed for use as an outcome measure. The results of repeated
administrations can be used to track functioning in relation to scale-score norms for the
child or adolescent’s age, gender, and type of informant (if using other forms). The data
provided by the Y-OQ allow clinicians to see actual change in scale scores and whether
scores have moved from the clinical range to the normal range.
Sensitivity to change. Sensitivity to change over brief periods of time is
evidenced by reliable decreases in Y-OQ total scores over the course of therapeutic
treatment for children and adolescents (Burlingame et al., 2001; Mosier, 1998). In a study
by Burlingame et al (2001) in which the RCI value of 13 and cut-off score of 46 were
utilized to assess sensitivity to change in a combined clinical sample, 147 (17%) subjects
were designated as recovered, 308 (37%) as improved, 260 (31%) as unchanged, and 125
(15%) as deteriorated. The average amount of change between pre- and posttest scores
was 17.7 points; this change is greater than the 13-point RCI value and reflects a change
of greater than 2 points per week.
The Y-OQ’s sensitivity to change is also evidenced by its ability to better
discriminate between children and adolescents with varying severity levels via sensitivity
and specificity analyses than the CBCL (Burlingame et al., 2001). According to
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and a specificity of 0.894; this means it will correctly identify those within the clinical
range 82% of the time and those within the sub-clinical or normal range 89% of the time.
Whereas, as indicated previously, the CBCL suggested cut-off of 60 (Achenbach &
Edelbrock, 1991) has a sensitivity index of 0.754 and a specificity of 0.870; this means it
will correctly identify those within the clinical range 75% of the time and those within
the sub-clinical or normal range 87% of the time.
Comparison of the CBCL/6-18, BASC-2 and Y-OQ-2.01
The CBCL/6-18 and the BASC-2 were designed to assess competencies and
problems in order to assist diagnosis and treatment planning. The Y-OQ-2.01 was
designed for use as an outcome measure and to track client progress. Although these
measures were designed for varying purposes they are all commonly used for outcome
purposes and are herein examined from that perspective.
Based on the above the reviews of the CBCL/6-18, BASC-2, and Y-OQ-2.01
Table 2.1 provides a relative comparison of all three measures in terms of the previously
identified recommendations made by researchers and clinicians to aid consumers in
choosing an ideal outcome measure. Some of the numbers presented are from previous
versions of the measures, when present statistics were not available. The rating system
employed uses the ratings of Poor, Moderate, and Good. These labels have been selected
to summarize the previous descriptions. Each rating reflects how the measure compares
to the other two measures on a particular dimension. The ratings of Restricted or
Unknown have been used when a rating within the general continuum from Poor to Good
was not clearly appropriate.
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Comparison of the CBCL/6-18, BASC-2 and Y-OQ-2.01 Based on Researchers’ and
Clinicians’ Recommendations
CBCL/6-18
Recommended Reliability 0.87-0.93
--.80

BASC-2

Y-OQ-2.01

0.78-0.95

0.94-0.97

Recommended Validity
Moderate -- .50
Excellent - -.75

0.59-0.86

Not presented

0.85

Valid for Change
Poor -- .20
Moderate -- .50
Good - -.80

Moderate to Good

Moderate to Good
(for most scales)

Good

Sensitive to Change

Restricted

Unknown

Good

Normed
-Cut-off scores
- RCI

-T-score cut-off
-No RCI

-T-score cut-off
-No RCI

-Raw score cut-off
-RCI

Can be Completed
Quickly

15-17 minutes

10-20 minutes, (30
minutes for SRP)

5-7 minutes

Can be Scored and
Interpreted Easily and
Quickly

Good-(Computer)
Moderate-(Hand)

Good-(Computer)
Poor-(Hand)

Good-(Computer)
Good-(Hand)

Provides Relevant
Information (Content
Domains) Regarding
Client Change

Activities
Social Competence
School Competence
Anxiety/Depression
Withdrawl/Depression
Somatic Complaints
Social Problems
Thought Problems
Attention Problems
Other Problems
Critical Items

Activities of Daily
Living
Adaptability
Aggression
Anxiety
Attention
Problems
Atypicality
Conduct Problems
Depression
Functional
Communication
Hyperactivity

Intrapersonal
Distress
Somatic
Complaints
Interpersonal
Relations
Social Problems
Behavior
Dysfunction
Critical Items
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Learning Problems
Social Skills
Somatization
Study Skills
Withdrawl
Can be Used Frequently
to Track Progress

Closest recommended
interval is 1 month,
most studies use 3
month intervals

Closest recorded
Weekly
interval for
outcome use is 2 ½
months, most
studies use 3
month intervals

Cost Effective (i.e.,
Inexpensive)

Forms: $.60
Scoring program:
$345.00

Forms: $1.12-1.76
Scoring programs:
start at $259.00
-depends on
desired features

Forms: Free
Scoring program:
starts at $75.00
-depends on size
of practice

Statement of the Problem
Sensitivity to change is the most important feature of an outcome measure
(Burlingame et al., 2005). In order to meet the needs of researchers, clinicians, and
health care managers, the measure must be sensitive to intra-individual changes that
occur as a result of a therapeutic intervention. Therefore, an outcome measure’s
sensitivity to change is vital in evaluating the effectiveness of psychotherapy for children
and adolescents.
This review has examined three measures commonly used in child and adolescent
outcome research and in clinical practice: the CBCL/6-18, the BASC-2, and the Y-OQ2.01. These three measures all have excellent reliability and validity estimates. It also
appears these measures are valid for evaluating change as evident by the many research
studies that have employed them for outcome use and produced moderate to high effect
sizes. However, there are concerns for the CBCL’s sensitivity to change within the
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Furthermore, sensitivity to change has not been directly compared across the CBCL/6-18,
BASC-2, and Y-OQ-2.01. A direct comparison of the sensitivity to change of these
measures will allow researchers, clinicians, and health care managers to identify the
measure that is most appropriately employed as an outcome measure. This would enable
outcome measure consumers to maximize the benefits that have been discussed
previously. Since sensitivity to change is the most important aspect of an outcome
measure (Burlingame, et al., 2005), if these measures are not significantly different in
regards to sensitivity to change, then outcome measure consumers can select a measure
based on other attributes (such as number of items, frequency of administration, or use of
additional forms such as that of a teacher-report) that they value for their particular
purposes.
Thus, the primary focus of this study was to evaluate the relative sensitivity to
change of the Child Behavior Checklist (CBCL/6-18), the Behavior Assessment System
for Children-2 (BASC-2), and the Youth Outcome Questionnaire (Y-OQ-2.01) in order to
identify the "best" measure for use in child and adolescent outcome research and to
recommend that it becomes the standard outcome assessment tool; such goals have been
suggested by researchers as desirable to advance outcome research (Froyd et al., 1996).
Analysis of Therapeutic Change
The statistical methods employed for outcome research are of the utmost
importance since different methods can use the same data for a particular client and come
to different conclusions about how to qualify the client (e.g., as improved, unchanged, or
deteriorated; see, for example Speer & Greenbaum, 1995). The statistical methods for
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To evaluate change that occurs at the individual level (intra-individual change), as well as
the group level (inter-individual differences), the statistical method must operate at
multiple levels. In other words, a statistical procedure for evaluating change must be able
to use all available information while detecting change at the individual and group levels.
Univariate or multivariate analysis of variance (ANOVA or MANOVA)
procedures have been commonly used by researchers to measure outcome on a
continuous basis (Kazdin, 2003; Raudenbush & Chan, 1993). However, these methods
are inappropriate when change studies contain unbalanced designs, missing data, timevarying covariates, or continuous predictors of rates of change (Ware, 1985). Such
characteristics are common in large-scale longitudinal studies (Raudenbush & Chan,
1993). Also, within these traditional models, individual variation in change is only
accounted for within the interaction of repeated occasions rather than being directly
modeled (Byrfk & Raudenbush, 1987, 2002). Therefore, Hierarchical Linear Modeling
(HLM) offers a more flexible analytic approach for assessing therapeutic change through
repeated measures data (Raudenbush & Chan, 1993).
HLM estimates linear equations that are used to explain outcomes for clients as a
function of their own individual characteristics, as well as the characteristics of the group
they belong to (i.e., the type of treatment they are receiving; Arnold, 1992). Although
HLM has been evolving since the 1970s, its application to the study of therapeutic
change is more recent. In the early 1970s, Lindley and Smith (1972) and Smith (1973)
developed the Bayesian method for the estimation of linear models with nested data and
complex error structures (Arnold, 1992). Later, Dempster, Laird, and Rubin (1977) and
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algorithm to estimate the covariance components of linear modeling. At each level in the
hierarchical model, the EM algorithm produces maximum likelihood estimates of the
variance and covariance components (Arnold, 1992). In the late 1980s, HLM became
more accessible to researchers with innovations in statistical computer programs (Arnold,
1992). With greater accessibility, many researchers in education and human
development began to use HLM in longitudinal studies (Bryk & Raudenbush, 1987). In
the 1990s, the mental health field recognized the benefits HLM had to offer and began
using HLM in the study of therapy outcome (see, for example: Raudenbush & Chan,
1993; Speer & Greenbaum, 1995).
HLM operates as a two-level hierarchical model: first, analyzing multivariate data
by computing individual growth curves, and, second, analyzing individual growth curves
as a function of a group (Arnold, 1992; Raudenbush & Chan, 1993). This procedure is
often referred to as nesting and is most often illustrated in the HLM literature with an
example of an educational setting—students nested within their classroom, classrooms
within their school, and schools within their school district. Nesting allows HLM to
accurately predict change for members of groups while accounting for the attributes of
both the member and the group (Arnold, 1992).
At level one, or the within-subject stage, each client’s change is represented by an
individual growth trajectory plus error that depends on a unique set of individual (personspecific) parameters (Bryk & Raudenbush, 1987; Raudenbush & Chan, 1993). These
individual parameters become the dependent variables in a level two analysis, or the
between-subjects stage (Raudenbush & Bryk, 2002). In other terms, regressions are
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variables in the regressions performed at the second level (Arnold, 1992). This two-stage
model utilizes person-specific parameters, such as background or type of therapeutic
treatment, to establish change trajectories which can be used to predict future change,
study variation in change, and assess the quality of measurement instruments. In other
words, the parameters of the first stage become the outcome variables in the second stage
(Bryk & Raudenbush, 1987; 1992; Speer & Greenbaum, 1995), providing a model for
analyzing individual and group patterns of change.
HLM has a number of advantages compared to traditional repeated measures
techniques. The most important advantage is the greater precision due to the use of
Bayesian estimation for assessing individual change in addition to group change
(Raudenbush & Chan, 1993; Speer & Greenbaum, 1995). Another advantage, perhaps
the most important for data collected within community mental health settings, is that the
EM algorithm accounts for missing data, so subjects do not need to be dropped or data
discarded due to limitations of the analytic model (Speer & Greenbaum, 1995). HLM
also allows for increased flexibility in data requirements due to nesting (Raudenbush &
Chan, 1993; Speer & Greenbaum, 1995). Clients may be assessed at different times and
on a varied number of occasions because the repeated observations are hierarchical data;
all observations are viewed as nested within the individual (Bryk & Raudenbush, 1987,
1992). Repeated observations decrease standard errors and provide consistent estimates
of parameter correlations, such as the rate of change correlated with a client’s initial
status (Speer & Greenbaum, 1995). Thus, HLM makes better estimates of change by
using all available information (Speer & Greenbaum, 1995).

- 50 There are important considerations for using HLM. Data must be highly reliable
and valid because they form the basis for the second-level analysis. Data must be
hierarchical, that is, units nested within groups. The groups must have enough withinsubjects and between-subjects classifications to provide sufficient degrees of freedom.
Large samples are recommended in the literature, but specifications on just how large
they should be are essentially nonexistent (Arnold, 1992). The same holds true for the
number of waves; typically more data points are considered better (Willett, 1989).
Finally, HLM involves performing regression of regressions; therefore, the assumptions
of linear regression that apply to causation cannot be applied (Arnold, 1992; Raudenbush
& Bryk, 2002).
Hypotheses
Based on the literature review herein presented, the hypotheses of this study were:
1. The Y-OQ-2.01 parent- and self-report versions will be more sensitive to
change over time and session number than the BASC-2 parent- and self-report
versions for a sample of outpatient children and adolescents.
2. The CBCL/6-18 parent- and self-report versions will be less sensitive to
change over time and session number than the BASC-2 parent- and self-report
versions or Y-OQ-2.01 parent- and self-report versions for a sample of
outpatient children and adolescents.
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Method
This study evaluated the relative sensitivity to change of the Child Behavior
Checklist/6-18 (CBCL/6-18), the Behavior Assessment System for Children-2 (BASC-2),
and the Youth Outcome Questionnaire (Y-OQ-2.01).
Measures
The CBCL/6-18, BASC-2, and Y-OQ-2.01 were each given to study participants,
with two versions for each measure: an adult informant measure (parent-report form) and
an adolescent self-report measure. The CBCL/6-18, BASC-2-PRS, and Y-OQ-2.01 were
administered to adult informants while the YSR, SRP, and Y-OQ SR-2.0 were given to
adolescents. Refer to page 21 through page 45 for a detailed description of these
measures. For the purposes of this study, the competencies portion of the CBCL/6-18 was
not used.
The Test-Taking Survey-Revised (TTS-R; McGrath, 2000) was used to infer
validity of the following analyses. The measure is a face-valid 10-item scale with letter
responses of N (Never), R (Rarely), S (Sometimes), F (Frequently), and AA (Almost
Always) corresponding to the scores 1, 2, 3, 4, and 5 points, respectively, with reverse
scoring on six items. The Test-Taking Survey was developed by Durham (1999, 2002) to
assess mechanical responding and revised by McGrath (2000) to omit a qualitative
section and add two questions relating to response style. Higher numbers on the TTS-R
indicate greater conscientiousness and thoughtfulness in filling out the measures.
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Valley Mental Health (VMH) is a community outpatient mental health facility
that provides services for over 18,000 people each year in Salt Lake, Summit, and Tooele
counties. VMH provides comprehensive services for children, adolescents, adults, and
seniors. Services include: inpatient, residential, and outpatient services; substance abuse
services, 24-hour crisis services, psychotropic medication management, forensic services,
case management, consultation, education services, and prevention services. VMH also
provides specialized services, such as for children with autism. The data for this study
was collected at VMH’s children’s outpatient services in Salt Lake City, Utah.
Outpatient mental health services included: individual, family, and group therapies;
medication evaluation and management; and crisis intervention. Services are provided by
psychiatrists, psychologists, clinical social workers, marriage and family therapists,
licensed practical nurses, and the like.
Sample
Outcome measures utilize various informants, most frequently the parent and
child or adolescent. According to De Los Reyes and Kazdin (2004), reviews of the
literature are consistent in showing little agreement between the ratings provided by
parents and children, with correlation coefficients often in the .20s. This discrepancy can
make it difficult to integrate data from multiple informants and can lead to differences in
who is perceived to meet particular criteria (Offord et al., 1996). However, the CBCL/618, BASC-2, and Y-OQ-2.01 consider a multi-informant feature important (Achenbach &
Rescorla, 2004; Kamphaus et al., 2004; Wells et al., 2003); each measure uses both
parent- and self-report versions of their instruments on a regular basis to assess children
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frequently than the self-report versions, Yeh and Weisz (2001) suggest that clinicians
who consult with children and adolescents may glean a better sense of shared parentchild goals for treatment than if they consulted with the parent alone. This agrees with
earlier research that found that children were better informants than their parents
(Herjanic & Reich, 1997). Therefore, both parent- and self-report versions continue to be
utilized within research and clinical settings.
Due to this continued use of both parent- and self-report versions of the measures,
data was collected from adults and adolescents. Children and adolescents, ages 6 to 17,
were included in the study to assess the widest range of ages allowable by the three
measures. These subjects were new clients beginning psychotherapeutic treatment at
VMH. All parents or significant adult figures of clients meeting the age requirement who
agreed to participate in the study were included. Adolescents who had consent of a
parent or legal guardian were also included, even if their parent chose not to participate.
The CBCL/6-18, BASC-2, and Y-OQ-2.01 were administered to 255 adults representing
these VMH clients. Self-report versions of the measures were also given to 100
adolescents ages 12 and above.
Procedures
The researcher received approval to conduct the study with human participants
from the Brigham Young University Institutional Review Board and the Utah
Department of Human Services Human Subjects Committee. Intake procedures,
treatment method, and treatment length were not altered in any way for the purposes of
this study. At the intake session, the Y-OQ-2.01 and Y-OQ SR-2.0 were given via
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VMH routine procedures. Parents and adolescents were informed of the purpose and
procedures of the study after Valley Mental Health’s intake session. Those who indicated
a desire to participate were given a packet and invited to return to the intake room after
their initial meeting with the therapist in order to enjoy snack foods and drinks while they
completed the packet. Parents and adolescents who chose to participate and did return to
the intake room signed a consent or assent form, respectively. They then filled out the
first set of measures which included the BASC-2 and the CBCL/6-18 presented in
random order to control for order effects. This initial packet did not include the Y-OQ2.01 since the Y-OQ-2.01 is given via PDA as part of Valley Mental Health’s routine
intake procedures before they meet with their therapist. After participants filled out the
BASC-2 and CBCL/6-18, the research assistant requested a print-out of the Y-OQ-2.01
from a Valley Mental Health receptionist and then added it to the packet of measures. Of
those 678 adults that were present at VMH intake sessions during the course of data
collection, 255 (37.6%) adults consented to participate and completed measures. One
hundred adolescents also participated. Some of those present at intake were not eligible
for the study since their child was younger than age 6.
The goal of the study was to obtain a maximum of five data points from each
participant, with the respective measures administered as close to once-per-month as
possible. This number of data points was selected because assessing sensitivity to change
requires a repeated-measures clinical sample (Burlingame et al., 2001) and researchers
have concluded that two time points do not provide adequate data for studying change
that may be non-linear (c.f. Bryk & Weisberg, 1977; Rogosa et al., 1982). This study
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psychotherapeutic treatment in real time.
The decision to collect the measures once-per-month was due to a number of
considerations relating to the various measures. The Y-OQ-2.01 was designed to be
administered as frequently as weekly, but can be used at any interval. However, the
CBCL/6-18 and the BASC-2 were designed to be used at greater intervals than weekly.
For example, Achenbach and Rescorla (2004) indicated the minimum amount of time
between assessments for the CBCL/6-18 should be one month, although previously
Achenbach (1991) indicated that period should be two months. Achenbach (1991) also
indicated that if the interval is reduced much below 6 months, it may reduce scores on
some problem items and scales slightly (such as running away or fire-setting), which
could make it difficult to interpret scores by comparing them with established norms.
Therefore, the appropriate timing of CBCL/6-18 administrations when it is used as an
outcome measure is not clear. It was observed in the literature that most studies use the
CBCL/6-18 at 3-month intervals. However, Achenbach and Rescorla most recently
(2004) indicated that the CBCL/6-18 can be administered every month to examine its
ability to detect change at more frequent intervals, so this timing was selected. BASC-2
authors (Kamphaus et al., 2004) have also recommended that it can be used to assess
outcome after “brief intervention programs” (p. 349). Although the shortest interval
observed for use as an outcome measure thus far appears to be 10 weeks (Merydith,
2000), it was determined to examine the BASC-2 administered on a monthly basis to
assess its sensitivity to change as an outcome measure over brief intervals, as well as
being consistent in administering it together with the other measures.
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possible, three weeks after a participant’s intake, the research team began to obtain
information on the participant’s upcoming appointments at Valley Mental Health. Once
an appointment was known, the research assistant traveling to Valley Mental Health on
the day of the appointment contacted the participant (or the participant’s parent if it was
an adolescent-only participant) to arrange to meet with them in the lobby of VMH. These
meetings were generally 30 minutes before their scheduled appointment, although more
time was allowed for those who felt they needed longer to fill out the measures, including
adolescents since the self-report form for the BASC-2 (SRP) is longer than the parentreport form. Participants received the CBCL/6-18, BASC-2, and Y-OQ-2.01 in a packet
with the measures presented in random order to control for order effects. It required
approximately 20- 40 minutes for participants to complete all three measures.
Due to the difficulty of securing repeated-measures data, researchers sought to
limit attrition by providing graduated compensation to clients (Kazdin, 2003) upon
completion of measures. Compensation was in the form of cash or gift certificates for
use at local venues. Participants were offered a five dollar value for a second or third
data collection point and a ten dollar value for a fourth or fifth data collection point.
Adolescents were also compensated when they filled out the measures.
Furthermore, potential participants were notified in the consent form that if they
chose to participate they gave permission to receive the measures by mail regardless of
whether they continued with treatment at Valley Mental Health. If a follow-up data point
was not obtained within a 3-month period, participants were contacted via email or
phone, and measures were mailed upon receiving an affirmative response regarding their
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Appendix A, a self-addressed envelope with postage, measures, and a gift-certificate to
compensate them for their time. This scenario was applicable for those who had
discontinued treatment at Valley Mental Health, had transferred to another unit, or had
continued to attend therapy but for various reasons the research team was unable to make
personal contact to secure measures.
Due to the difficult nature of acquiring repeated-measures, in order to provide
debriefing to the maximum number of participants, a debriefing statement was provided
to each participant (parent and adolescent) at the third administration of measures, though
efforts continued to obtain as many as five data points. Along with this debriefing
statement, inquiry was made regarding participant attitudes with which they filled out the
measures, and their conscientiousness in filling out the measures in order to infer validity
of obtained results. This inquiry was accomplished with the use of the Test-Taking
Survey-Revised (TTS-R). The revised Test-Taking Survey and debriefing statement as
presented to the research participants is provided in Appendix B.
Scoring of Measures
This study sought to administer and score measures in a naturalistic manner, as
would clinicians in routine practice. Therefore, the CBCL/6-18 and the BASC-2 were
scored via publisher scoring programs purchased by Brigham Young University’s
Psychology Department. The Y-OQ-2.01 was scored using a scoring syntax provided by
the developers of the Y-OQ-2.01, which scored the Y-OQ-2.01 as it would be scored by
clinicians purchasing their software, yet without some of the features their software
provides that were not needed for this study (such as graphs tracking individual client
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T-scores; the Y-OQ-2.01 presents results to clinicians in summative raw scores.
Screening to Obtain Final Analytic Sample
Two discrete screening procedures identified the final analytic sample for this
study. First, in order to calculate change, a minimum of two data points is required. Of
the original sample of 255, 108 cases were omitted from the analytic sample because they
had only one data point, leaving 147 cases. Second, due to the comparative nature and
purpose of this study, no cases were included in the analysis that did not show reliable
change based on RCI values (in either direction: improved or deteriorated) on any of the
three measures, either by parent- and/or self-report versions of a measure. Cases showing
reliable change on one or two measures at any point within treatment (i.e. between any
data collection points, even if the change from pre- to post-treatment was not reliable)
were retained in the analysis. Therefore, the next step in obtaining the analytic sample
was to calculate respective RCI scores for the remaining 147 cases.
Burlingame et al. (2005) suggested that for tracking client changes with the YOQ-2.01 the Total score should be selected for use, rather than subscale scores. Thus,
these analyses are based on changes in client Total scores. The RCI of 13 that has been
calculated by authors of the Y-OQ-2.01 was used to evaluate changes in raw scores on
the Y-OQ-2.01; the calculated RCI value of 18 was used for the Y-OQ SR-2.0. Since the
BASC-2 and the CBCL/6-18 do not employ the use of RCI, these scores were calculated
using the following formula (Tingey, Lambert, Burlingame, & Hansen, 1996):
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Sdiff
Sdiff = √2SE2
SE = SD√1 - rxx
The rxx is the mean of the correlations between all sets of half the items
comprising a scale and was determined by the internal consistency estimates in the
respective manuals provided as Cronbach’s Alpha (rxx). The standard deviation (SD),
using the CBCL/6-18 and the BASC-2 T-scores, is equal to 10.
The representative scale of the CBCL, Total Problems, is from its empirically
based scales. The Total Problems score is the sum of all the problem scales and is the
most global index of psychopathology on the CBCL/6-18 (Achenbach & Rescorla, 2004).
Achenbach and Rescorla (2001) indicate: “The Total Problems score can also be used as
a basis for comparing problems in different groups and for assessing change as a function
of time or interventions” (p. 192). For the parent-report of CBCL/6-18 the rxx = .97, and
for the adolescent self-report version (YSR) the rxx = .95. Calculations produced an RCI
of 4.80 for the CBCL and 6.20 for the YSR.
The representative scale for the parent-report version of the BASC-2-PRS is the
Behavioral Symptoms Index (BSI), and for the self-report version of the BASC-2-SRP it
is the Emotional Symptoms Index (ESI). Reynolds and Kamphaus (2004) indicated that
the BSI and ESI reflect the overall level of a child’s or adolescent’s problem behavior
and recommended that these overall composites be examined first when interpreting
results. Chronbach’s Alpha for the PRS: BSI and SRP: ESI vary by age of the child. For
the PRS ages 6-7 and ages 15-18, rxx = .94; for ages 8-11 and ages 12-14, rxx = .95. For
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6.80 for those using rxx = .94, and an RCI of 6.20 for those using rxx = .95.
A case was identified for inclusion in the analytic sample if the absolute value of
the calculated change was greater than, or equal to, the RCI criteria for at least one of the
given measures, thus identifying cases where children and adolescents reliably improved
and reliably deteriorated at any point during psychotherapeutic treatment. Although the
RCI of 13 used for the Y-OQ-2.01 (18 for the Y-OQ SR-2.0) was based on raw scores,
the analysis used T-scores for the CBCL/6-18 and BASC-2 due to an effort to use the
measures as they would be used in naturalistic fashion within a clinical setting. A
summary of the RCI’s calculated for the CBCL/6-18 and BASC-2 from their T-scores is
presented in Table 3.1.

Table 3.1
RCI Values for the CBCL/6-18 and BASC-2
Measure

Informant

Ages

Alpha (rxx)

RCI

CBCL/6-18

Parent (CBCL)

6-18

.97

4.8

Youth (YSR)

12-18

.95

6.2

Parent (PRS)

6-7; 15-18

.94

6.8

8-11; 12-14

.95

6.2

12-14

.95

6.2

15-18

.94

6.8

BASC-2

Youth (SRP)
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inclusion in the analytic sample. Of these cases, 92 cases were parent or adult informants
only, while 42 had corresponding adolescent informants. In addition, there were two
adolescent informants who were retained in the analysis whose parents did not
participate.
Twenty-eight adult informants, 21% of the 136 cases retained in the analysis,
completed one or more packets of measures via mail at some point during their tenure in
the study. Eight of these 28 cases had corresponding self-report measures filled out by an
adolescent. A t-test on the pair-wise test of differences between the change slopes of
these participants and those participants that completed all sets of measures at Valley
Mental Health with one of the study’s research assistants indicated there were no
statistical difference in the two groups (p = .57). Therefore, this group was included
within the analytic sample for all comparisons, and not treated separately within the
analysis.
As presented earlier, the BASC-2 employs the use of three parent-report forms,
two of which are used in the present study: the Parent Rating Scales-Child (PRS-C) for
ages 6-11 and the Parent Rating Scales-Adolescent (PRS-A) for ages 12-21. The PRS-C
has 160 questions, 132 (82.5%) of which are identical to questions in the PRS-A. The
PRS-C has 23 questions that are different from the PRS-A (14.38%) and five questions
which are similar to questions on the PRS-A (two of them are related to the same PRS-A
question; 3.13%). The PRS-A has 150 questions, 132 (88%) of which are identical to
questions in the PRS-C, 13 (8.66%) of which are different from those in the PRS-C and
five (3.33%) of which are related to questions found in the PRS-C. The PRS-C and PRS-
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2004). A statistical comparison between the slopes created by the PRS-C to the change
slopes of the PRS-A indicated there were no statistical differences in the two groups. For
cases where the child or adolescent improved during the course of the study, as identified
by the Y-OQ-2.01, the p value was non-significant at .65; for those cases where the child
or adolescent deteriorated during the course of the study the p value was non-significant
at .79. Therefore, these measures were not treated separately within the analysis.
Analyses
After change was evaluated by calculating the RCI to obtain the analytic sample,
the RCI was also used to evaluate pre- to post-treatment change that qualified children
and adolescents improved. Change was further evaluated by using cut-off scores in
tandem with the pre- to post-treatment RCI to evaluate how each of the measures
classified changed cases as recovered.
Finally, to calculate effect size, Hierarchical Linear Modeling (HLM) was used to
determine which of these measures may be most appropriate or most helpful for outcome
use. HLM addressed this question by calculating individual slopes for each subject for the
CBCL/6-18, the BASC-2 and the Y-OQ-2.01 (i.e., each individual had three slopes);
these slopes represented rates of change. The analysis determined if there was a
significance difference in the slopes. With statistically significant different slopes, the
measure with the steepest negative slope was considered to be the most sensitive to
change.
The CBCL/6-18, BASC-2, and Y-OQ-2.01 use different methods for interpreting
clients’ scores; the CBCL/6-18 uses T-scores, the BASC-2 uses linear T-scores, and the
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standardized in order to allow the slopes to be compared relative to each other; this was
done by transforming them so they had equivalent scales. Linear T-scores vary from Tscores in that the distribution is not normalized, so the associated percentiles are different
from those of T-scores. However, linear T-scores have a mean of 50 and a standard
deviation of 10 as do T-scores, so no transformation was necessary for the CBCL/6-18
and BASC-2. The Y-OQ-2.01 data was transformed using the formula 10(Y-x̄ )/SD+50
where Y was equal to a participant’s raw score on the Y-OQ-2.01, x̄ was equal to the
mean of Y-OQ-2.01 scores for a normal population, and SD was equal to the standard
deviation of a normal population. The parent-report Y-OQ-2.01 mean and SD were 21.4
and 26.42, respectively (Burlingame et al., 2005) and the Y-OQ SR-2.0 mean and SD
were 34.37 and 29.42, respectively (Ridge, Warren, Burlingame & Wells, 2007). This
transformation gave the Y-OQ-2.01 and the Y-OQ SR-2.0 means of 50 and standard
deviations of 10.
Thereafter, the data was analyzed according to the two models. Models were
estimated using SAS for Windows (PROC MIXED; maximum likelihood estimation;
version 9.1; SAS Institute, Inc., Cary, NC). The first model has a time variable; the
second model replaces the time variable with a dosage variable, examining number of
therapeutic contacts or sessions:
1. Y = O + M + O * M + I + O * I + M * I + O * M * I + log(D) + O * log(D) + M
* log(D) + O * M * log(D) + I * log(D) + M * I * log(D) + O * I * log(D) + O * M * I * log(D).
In analytic model number one, Y was equal to a participant’s score on each of the
measures, O was the outcome of the child’s therapy (improved or deteriorated) as
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the HLM analysis, one measure was required to be the standard to which the other
measures were compared. The Y-OQ-2.01 was selected as the statistical standard due its
use by Valley Mental Health as their intake measure, as well the presence of evidence for
sensitivity to change as presented in the literature review. M was the method of
measurement (CBCL/6-18, BASC-2, or Y-OQ-2.01) that represented a class variable that
produced three different intercepts and slopes for the three different methods, I was the
informant providing the data (parent- or self-report), and D was equal to the day number,
with intake as day number one. The natural log function of the time variable (log(D)) was
chosen, as other research suggests it is a better fit for this type of data than is a simple
linear function (e.g., Warren, Nelson, & Burlingame, 2008).
The element O * M represented a two-way interaction examining a measure used
to gather the data (CBCL/6-18, BASC-2, and Y-OQ-2.01) relative to a child’s final or
post-treatment score as improved or deteriorated from intake. O * I is the interaction
between outcome and informant. M * I examined how the measures performed relative
the informant used to provide the data. O * M * I represented a three-way interaction
between a child or adolescent’s outcome, the method of measurement, and the informant.
The element O * log(D) represented a two-way interaction between the outcome of
therapy, as established by a decrease or increase in Y-OQ-2.01 scores and day number
averaged across the respective outcome classifications of improved and deteriorated. M
* log(D) represented a two-way interaction between the measure and the day number
averaged across all three measures. O * M * log(D) represented a three-way interaction
between outcome, measure, and the day number, while the element I * log(D) represented
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types of informants. M * I * log(D) represented a three-way interaction between the
measure, the informant, and day number. O * I * log(D) was the interaction between
outcome, informant, and day number. The last element of the model, O * M * I * log(D),
represented a four-way interaction between measure, informant, outcome, and day
number. In comparisons not including the youth informants, the informant element
(element I) was removed from the model.
2. Y = O + M + O * M + I + O * I + M * I + O * M * I + log(V) + O * log(V) + M
* log(V) + O * M * log(V) + I * log(V) + M * I * log(V) + O * I * log(V) + O * M * I * log(V).
In the second analytic model, V was equal to session or therapeutic contact number
(intake counts as session one) in order to also track dose of therapy. A dose of therapy
was defined by therapeutic contact at Valley Mental Health including intake, individual
therapy sessions, family therapy sessions, medication evaluations, and the like.
The analyses for these two models focused on the interactions that were
statistically significant to allow conclusions as to which measure is most sensitive to
change and which type of informant is most sensitive to change. These models addressed
both of the study’s hypotheses regarding the relative sensitivity to change for the three
measures. It further examined which type of informant data is most sensitive to change.
In this study the informants provided variable frequencies of data; anywhere from
two data points through five data points were collected. However, the analysis proceeded
regardless of the number of data points obtained for each measure, since HLM is
designed to examine variable frequencies of data.
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individual growth trajectories; these varied by individual participant. This initial analysis
took into account covariates that may have affected the trajectory of the slope: initial
score (initial severity) and age of client. Initial score has been commonly found to affect
treatment trajectory (e.g., Lambert, 2007); age of client was selected as a covariate due to
analyses such as those from the Y-OQ-2.01 and the Y-OQ SR-2.0 where researchers
(Burlingame et al., 2005; Wells, Burlingame, & Rose, 2003, respectively) found
significant differences in their analyses based on the age of the child or adolescent.
These individual growth trajectories then became the dependent variables in level
2 where HLM took the average of the slopes and generated an estimate of the population.
Slopes calculated using the estimates from stage 2, were used to draw conclusions
regarding the relative sensitivity to change of the CBCL/6-18, BASC-2, and Y-OQ-2.01;
these results are presented in Chapter 4.
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Results
Sample Demographics
The final analytic sample for comparing the sensitivity to change for the CBCL/618, BASC-2, and Y-OQ-2.01 included 136 child or adolescent cases. Of these cases,
there were 134 adult informants reporting on 68 (50%) females and 68 (50%) males.
Forty-four adolescents (25 females and 19 males) also served as informants by
completing self-report measures; 42 of these adolescents filled out measures in addition
to the measures filled out by their parent or significant-adult figure, while 2 of these
adolescents participated alone. Thus, there were a total of 178 informants in this study
for 136 cases.
The average age of the children and adolescents in the study was 10.76 (SD =
3.53). The median age was 10.07 and the mode age was 7.32. The average age of males
was 10.19 (SD = 3.25); the median age was 9.4, and the mode was 8.68. The average age
of females was 11.22 (SD = 3.73); the median age was 11.5, and the mode was 8.69. An
independent sample t-test indicated there were no statistically significant differences in
the mean ages between males and females (p = .06). A t-test on the pair-wise test of
differences between the HLM change slopes of those adult informants who completed
measures for females compared to those completing measures for males indicated there
was no statistical difference in the two groups (p = 0.83), indicating adults were not
reporting change differently for males and females. Therefore, gender was not treated
separately within the analysis.
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This study sought to obtain up to five data points collected from each informant,
with adults filling out the CBCL/6-18, BASC-2, and Y-OQ-2.01 at each data collection
point and adolescent informants filling out the CBCL/6-18 YSR, BASC-2-SRP, and YOQ SR-2.0. The number of data points obtained from this analytic sample is presented in
Table 4.1. As can be seen, 79 informants filled out the CBCL/6-18, BASC-2, and Y-OQ2.01 two times. Thirty eight informants provided completed measures three times, 29
informants provided measures four times, and 32 informants filled out measures five
times over the course of their tenure in the study. Thus, there were 548 data points
obtained in this study.

Table 4.1
Frequencies and Total Number of Data Points Collection from the 178 Informants for
136 Cases Retained in the Analytic Sample

Total
Total Number
Number of
of Data
Cases with Informants
Points (Number
Only
of Data Points
Adolescent
Obtained
x Total
Informants

Number of
Data
Points
Obtained

Number of
Adult
Informants

Number of
Corresponding
Adolescent
Informants

2

58

19

2

79

158

3

25

13

0

38

114

4

22

7

0

29

116

5

29

3

0

32

160

Total

134

42

2

178

548

Informants)
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completed until five data points were completed. The shortest span of time between
intake and the last secured data point was 24 days (e.g. Case #315). The longest span of
time between intake and the final secured data point was more than a year at 381 days
(e.g. Case #168). The average tenure for participants was 122 days, a length of just over
4 months. The median length of time in the study was 112 days; the distribution had a
mode of 120 days with five cases.
The average number of days between data collection points was 56.72 with an SD
of 36.68. Due to the influence of several outliers, the median and mode are considered
more accurate representations of the timing involved with data collection: the median is
44 days and the mode is 21 days. The mode is representative of the study’s efforts to
secure data points beginning at the third week after intake or the last data point in order to
obtain data as close to once per month as possible throughout the participant’s tenure in
the study, as it often required several attempts to secure completed data.
The total number of sessions, or therapeutic contacts, for the 136 cases of the
analytic sample was 1,566. These services were provided largely by clinical social
workers, social workers, and psychiatrists. Table 4.2 summarizes the frequencies of
services provided, while Table 4.3 summarizes provider disciplines and the percentage of
services those providers offered to study participants.
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Frequencies of Services Utilized by Study Participants

Service Provided

Frequency

Percentage

Psychiatric Diagnostic Interview (Assessment/Evaluation)

167

10.7%

Assessment Dictated with Client Present

37

2.4%

Individual Psychotherapy

186

11.9%

Individual Therapeutic Behavioral Services

1

0.1%

Individual Psychotherapy with Medication Management

2

0.1%

Pharmacologic Management (Medication Management)

177

11.3%

Family Psychotherapy with Client Present

785

50.1%

Family Psychotherapy without Client Present

30

1.9%

Family Therapeutic Behavioral Services

2

0.1%

Multiple Family Psychotherapy

46

2.9%

Group Psychotherapy

133

8.5%

Total

1566

100%
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Provider Disciplines with Frequencies of Services Provided by these Disciplines

Frequency of

Percentage of

Services

Services

Psychiatrist

182

11.6%

Psychologist

90

5.7%

Clinical Social Worker

653

41.7%

Social Worker

467

29.8%

Registered Nurse

4

0.3%

Social Service Worker

2

0.1%

Advanced Practical Nurse

62

4.0%

Licensed Professional Counselor

106

6.8%

1,566

100%

Provider Discipline

Total

The range of services for participants was from two sessions to 48, with one
outlier having 110 therapeutic services (Case #138). Excluding this outlier, the average
number of therapeutic contacts, or sessions, was 11 with an SD of eight. The median was
nine sessions and the mode was four.
Race of the 136 children and adolescents is presented in Table 4.4 with the largest
represented populations self-identified as white (n = 111, 81.6%) and of Hispanic origin
(n = 14, 10.3%).
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Race of 136 Children and Adolescents in Analytic Sample
Race

Frequency

Percentage

American Indian-Native Alaska

2

1.5%

Pacific Islander

3

2.2%

Black

2

1.5%

White

111

81.6%

Hispanic origin

14

10.3%

Asian

1

0.7%

Other

3

2.2%

Total

136

100%

One-hundred and eighteen (86.8%) of these children were identified as Severely and
Emotionally Disturbed (SED), 14 (10.3%) were not identified as SED, and 4 (2.9%) did
not specify status. To illustrate levels of symptom distress for this population, Table 4.5
provides intake score data. Since the Y-OQ-2.01 and Y-OQ SR-2.0 raw scores were
transformed into T-scores for these analyses, yet the Y-OQ-2.01 uses raw scores for
client tracking, both raw score and T-score variables are included in this table for
descriptive purposes.
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Intake Scores from 178 Informants: Adult and Adolescent Measures
Measure
CBCL/6-18

BASC-2

Y-OQ-2.01

Informant

Mean

Median

SD

Range

Parent

69.66

71

6.90

49-88

Youth (YSR)

65.96

65

9.65

42-88

Parent (PRS)

70.92

69

11.81

42-105

Youth (SRP)

62.64

61

12.66

42-87

Parent

76.59

75.97

11.23

48-100

Youth (SR 2.0)

65.96

65.17

10.99

44-89

Parent

91.65

90

29.67

15-153

Youth (SR 2.0)

81.31

79

32.33

17-148

(T-Scores)

Y-OQ-2.01
(Raw Scores)

An independent t-test between these 136 analytic sample cases and the 119 cases
recruited from intake that did not become part of the analytic sample indicated there was
no statistical difference between the means of the intake scores for any of the parent- and
self-report versions of the CBCL/6-18, BASC-2, and Y-OQ-2.01. Thus, the means of the
intake scores of the 108 cases that did not continue in the study, and the 11 cases that did
provide two data points but did not show reliable change, were not statistically different
from those that continued in the study and showed reliable change at some point in
treatment.
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Validity of the following analyses was inferred from the Test-Taking Survey
Revised (TTS-R; McGrath, 2000). A total of 70 adults filled out the TTS-R, 21 of which
had corresponding youth that also completed the measure. With a five point Likert scale,
higher numbers indicated more thoughtfulness in filling out the measures. The adult
mean was 4.41 with an SD of 0.36 and the mode was five; the youth mean was 3.61 with
an SD of 0.74; the mode was four. With these high reports of thoughtfulness and
conscientiousness while answering the questions presented in the CBCL/6-18, BASC-2,
and Y-OQ-2.01, results of this study were inferred to be valid.
Although the study sought to obtain one TTS-R from each informant, 17 adults
and three adolescents completed the TTS-R a second time. A matched-sample, or paired
samples, t-test of this adult group compared scores from the first administration to the
second and found the first administration had a mean of 4.51 with an SD of 0.31, and the
second administration had a mean of 4.45 and an SD of 0.31. However, the paired
differences were not significantly different from each other (2-tailed, p = 0.36) indicating
that parents had continued conscientiousness in attending to the questions as they
completed the three measures.
Descriptive Analysis of Change
RCI Change at Any Point in Treatment
The manner by which the three measures evaluated change was first examined
using the reliable change index (RCI). A crosstabulation comparing the RCI variables
created for the CBCL/6-18, BASC-2, and Y-OQ-2.01 identified the cases that were
recognized by each measure as showing reliable change in either direction (improved or
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within treatment (by parent- and/or self-report versions of a measure), each measure
identified cases the other two also identified; each measure identified cases that one of
the other measures also identified, but the third measure did not; and each measure
identified cases that the other two measures did not identify. Due to missing data, 133 of
the study’s cases are accounted for within this crosstabulation. All three measures
recognized 63 of the cases as meeting RCI inclusion criteria while there were 70 cases
recognized for inclusion in the analytic sample that were identified by only one or two of
the measures. These 70 cases identified by a single measure or a combination of two
measures are presented in Table 4.6.

Table 4.6
Number of Cases Identified as Meeting RCI Change Criteria by a Single Measure or a
Combination of Two Measures for Cases in which there was Not Agreement
CBCL/6-18

BASC-2

Y-OQ-2.01

Total

CBCL/6-18

6

7

14

27

BASC-2

7

6

22

35

Y-OQ-2.01

14

22

15

51

As shown in Table 4.6, the CBCL/6-18 identified a total of 27 cases alone or in
combination with another measure; the BASC-2 identified 35 cases, and the Y-OQ-2.01
identified 51 cases as meeting RCI change criteria either alone or in combination with
another measure was 51. Thus, it appears the Y-OQ-2.01 is most sensitive to changes
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analytic sample, while the BASC-2 is more sensitive to identifying changes that occur
than the CBCL/6-18.
By presenting cases recognized for RCI inclusion in the analytic sample, Table
4.6 implicitly provides information regarding cases that were not identified as meeting
RCI change criteria by a measure or combination of measures. To further describe the
performances of the CBCL/6-18, BASC-2, and Y-OQ-2.01, Table 4.7 presents the total
number of cases that have been included in the analytic sample (i.e. they were identified
as meeting RCI criteria by at least one measure) that were not identified by a particular
measure or its combination with another measure as meeting RCI change criteria.

Table 4.7
Number of Total Cases Not Identified by a Measure or Combination of Two Measures as
Meeting RCI Change Criteria for Study Inclusion
CBCL/6-18

BASC-2

Y-OQ-2.01

Total

CBCL/6-18

22

15

6

43

BASC-2

15

14

6

35

Y-OQ-2.01

6

6

7

19

As shown in Table 4.7, the CBCL/6-18 identified a total of 43 cases as showing
no reliable change that were identified by either the BASC-2 alone, the Y-OQ-2.01 alone,
or both of those measures as meeting RCI change criteria for inclusion in the analytic
sample; the BASC-2 identified 35 cases, while the Y-OQ-2.01 identified a total of 19
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number of cases showing no reliable change, while the Y-OQ-2.01 was the most sensitive
to change by having the least number of cases identified as such.
Beyond this, a purer test of whether a participant’s score changed was when two
of the three measures identified said change. According to this criterion, as presented in
Table 4.7, of those cases included in the analytic sample due to their identification by two
of the measures for reliable change, the CBCL/6-18 had 22 cases showing no reliable
change, while the BASC-2 had 14 cases and the Y-OQ-2.01 had seven cases. Thus, in
regards to these frequencies, the Y-OQ-2.01 was most sensitive to identifying change, in
that it did not identify the least amount of cases corroborated for reliable change by two
measures, while the BASC-2 was more sensitive to identifying changes than the
CBCL/6-18.
Pre- to Post-treatment RCI Change
The 136 cases of the analytic sample included all cases from the original sample
that met RCI criteria according to the parent- and/or self-report versions of one of the
measures at any point within their tenure in the study. An examination of initial intake
scores compared to scores from the final data collection point (i.e. pre- to post-treatment)
indicated that 81 (59.5%) met RCI criteria according to the CBCL/6-18, 86 (63.2%) met
RCI criteria according to the BASC-2, while 95 (69.9%) met pre- to post-treatment RCI
criteria according to the Y-OQ-2.01. Table 4.8 indicates the number of cases improved
and deteriorated in these RCI totals.
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Cases Identified by the CBCL/6-18, BASC-2, and Y-OQ-2.01 as Meeting RCI Change
Criteria Pre- to Post-treatment from 136 Cases in the Analytic Sample
Improved

Deteriorated

Total

CBCL/6-18

60

21

81

BASC-2

57

29

86

Y-OQ-2.01

74

21

95

Relative to the manner in which each measure recognized change at any point in
treatment for determining inclusion in the analytic sample, the measures performed in
like fashion indentifying change from pre- to post-treatment. The Y-OQ-2.01 identified
the greatest number of cases as exhibiting reliable change, while the BASC-2 identified
the next greatest number and the CBCL/6-18 identified the fewest number of cases.
A crosstabulation comparing the RCI variables from pre- to post-treatment for the
CBCL/6-18, BASC-2, and Y-OQ-2.01 showed how the cases that were recognized by
each measure as showing reliable change in either direction (improved or deteriorated)
were identified by the other measures. When data was combined there were 127 valid
cases within this crosstabulation. There was RCI agreement among all three measures’
parent- and/or self-report versions for 52 cases: 47 of the cases were identified as meeting
RCI pre- to post-treatment criteria and can be classified as reliably improved or reliably
deteriorated, while five cases were identified as not meeting RCI pre- to post-treatment
criteria. Of the 47 cases showing reliable change, 35 cases were identified by all three
measures as reliably improved and 6 cases were identified by all three measures as
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measures as showing reliable pre- to post-treatment change for which the measures had
disagreement as to the nature of the change (i.e. one measure classified a case as reliably
improved while another measure classified the same case as reliably deteriorated).
Thus, 75 of the 127 cases compared in this crosstabulation did not have pre- to
post-treatment agreement between the three measures. These 75 cases, as recognized by
a single measure or combination of measures, are presented in Table 4.9.

Table 4.9
Number of Cases Identified as Meeting Pre- to Post-treatment RCI Change Criteria by a
Measure or Combination of Two Measures for Cases in which there was Not Agreement
CBCL/6-18

BASC-2

Y-OQ-2.01

Total

CBCL/6-18

9

9

14

32

BASC-2

9

13

15

37

Y-OQ-2.01

14

15

15

31

As shown in Table 4.9, each of the three measures identified cases as reliably changed
that the other measures did not identify. The CBCL/6-18 identified nine cases that the
BASC-2 and Y-OQ-2.01 did not identify. The BASC-2 identified 13 cases that the
CBCL/6-18 and Y-OQ-2.01 did not identify. The Y-OQ-2.01 recognized 15 cases as
meeting RCI change criteria that the CBCL/6-18 and the BASC-2 did not recognize.
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identified as meeting pre- to post-treatment RCI criteria that were not identified by it or
its combination with another measure.

Table 4.10
Number of Total Cases Not Identified by a Measure or Combination of as Meeting RCI
Pre- to Post-treatment Change Criteria
CBCL/6-18

BASC-2

Y-OQ-2.01

Total

CBCL/6-18

28

15

13

56

BASC-2

15

14

9

38

Y-OQ-2.01

13

9

9

31

In addition to the total number of cases, Table 4.10 highlights the purer test of change by
identifying the number of cases not identified for change when the two other measures
did so. The CBCL/6-18 did not identify 28 cases that were identified by both of the other
measures, while the BASC-2 did not identify 14 cases, and the Y-OQ-2.01 did not
identify 9 cases. This suggests that the Y-OQ-2.01 had the greatest level of corroboration
with the other measures.
Cut-off Score Analysis
Cut-off scores are discrete cut-off points that represent the point a score must fall
below to classify cases from clinical and sub-clinical, or normal, populations. Due to the
measurement error inherent in the use of these points, the CBCL/6-18 has provided a
borderline range (T-scores of 60-63) and the BASC-2 has provided an at risk range (T-
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longer considered within the clinical range. In order to compare the CBCL/6-18 and
BASC-2 to the Y-OQ-2.01 that does not provide borderline descriptors, the borderline
and at risk ranges needed to be collapsed into dichotomous categories of normal and
clinical populations. There are three ways in which this could be done with various
justifications; thus all three options were calculated and are presented herein.
First, the borderline descriptors were collapsed into the normal population, as
CBCL/6-18 T-scores of 64 and above are classified as clinical and the BASC-2 classified
T-scores of 70 and above as clinical. This, however, leaves all measures with discrepant
standards in regards to the cut-off scores: the CBCL/6-18 approximately one-and-a-half
SD above the mean, the BASC-2 is two SD above the mean, and the Y-OQ-2.01 is one
SD above the mean.
Second, the CBCL/6-18 borderline range was collapsed with T-scores of 60 and
above identified as clinical. This is justified by Achenbach and Rescorla (2001): “For
efficient dichotomous discrimination between deviant and nondeviant scores, the
borderline clinical range can be combined with the clinical range by classifying T-scores
≥60 as deviant on the Internalizing, Externalizing, and Total Problems scales” (p. 96).
This equalized the CBCL/6-18 with the Y-OQ-2.01 with cut-off scores that resided one
SD above the mean.
Third, with the shift in the CBCL/6-18 to a cut-off T-score of 60, the BASC-2
remained at a cut-off score of 70 (two SD above the mean) though the two measures are
both on standardized scales; with intention to equalize all three measures to the same
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lowered from a T-score of 70 to 60.
A comparison of the pre- to post-treatment scores of each measure produced four
categories of change as reported by a parent- and/or self-report version of a measure:
1. Clients that started in the clinical range and crossed the cut-off score into the
normal range (i.e. recovered);
2. Clients that started in the normal range and crossed the cut-off score into the
clinical range (i.e. entered clinical);
3. Clients that started in the clinical range and remained in the clinical range (i.e.
remained clinical);
4. Clients that started in the normal range and remained in the normal range (i.e.
remained normal).
In the following tables, categories 1 and 2 are presented together as they include all cases
that crossed cut-off scores, while in categories 3 and 4 are presented together as they
include all cases that did not cross cut-off scores. A summary of the findings for the first
variation in collapsing three descriptor categories into two, including borderline
descriptors in the normal range, are presented in Table 4.11 and Table 4.12.
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Number of Cases Crossing Cut-off Scores using Pre- to Post-treatment Data: Borderline
Descriptors for CBCL/6-18 and BASC-2 Collapsed into Normal Range
Recovered

Entered Clinical

CBCL/6-18

30

4

Total Cases
Crossing Cut-off
34

BASC-2

34

13

47

Y-OQ-2.01

21

1

22

A chi-squared (χ2) analysis of these findings, indicated that there was no significant
difference [(2, N = 85) = 3.13, p = .21] between the measures in regards to frequencies of
cases that recovered, but significant difference [(2, N =18) = 13, p = 0.01] between the
measures for those cases which entered the clinical range.

Table 4.12
Number of Cases Not Crossing Cut-off Scores using Pre- to Post-treatment Data:
Borderline Descriptors for CBCL/6-18 and BASC-2 Collapsed into Normal Range
Remained Normal

CBCL/6-18

Remained
Clinical
88

12

Total Cases Not
Crossing Cut-off
100

BASC-2

42

47

89

Y-OQ-2.01

108

5

113
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measures in regards to frequencies of cases they categorized as remained clinical or
remained normal [(2, N = 238) = 28.87, p < .01; (2, N = 64) = 47.47, p < .01,
respectively].
The BASC-2 had the greatest total number of cases crossing the cut-off while the
Y-OQ-2.01 had the least number of cases crossing the cut-off score. This first variation,
in collapsing borderline descriptors into the two categories of normal and clinical,
produced results that are not consistent with the general findings of this study, and due to
differences in criteria for establishing cut-off scores among the three measures, these
results should be interpreted with caution.
A crosstabulation of these pre- to post-treatment cut-off scores for the CBCL/618, BASC-2, and Y-OQ-2.01 support this assessment. The analysis yielded 133 valid
cases of the 136 in the analytic sample. Of these, there was a relatively low level of
agreement between the measures. Fifty-five cases (41%) were classified within the same
category by all three measures, with nine cases ranked as recovered, 41 cases ranked into
remained clinical, and five cases ranked into remained normal. Interestingly, this
comparison reveals there was no agreement between the three measures regarding the
category entered clinical, cases where a child or adolescent had begun in the normal
range and deteriorated to the clinical range.
Results for the findings for the second variation, three borderline descriptor
categories collapsed into two by changing the CBCL/6-18 cut-off score from 64 to 60
while leaving the BASC-2 at risk borderline descriptor collapsed into the normal range,
are presented in Table 4.13, and Table 4.14.
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Number of Cases Crossing Cut-off Scores using Pre- to Post-treatment Data: CBCL/6-18
Cut-off Score Adjusted from 64 to 60 with BASC-2 ‘At Risk’ Category Collapsed into
Normal Range
Recovered

Entered Clinical

CBCL/6-18

20

3

Total Cases
Crossing Cut-off
23

BASC-2

34

13

47

Y-OQ-2.01

21

1

22

A χ2 analysis, indicated that there was no significant difference in how the measures
preformed in regards to identifying cases that recovered [(2, N = 75) = 4.88, p = .08], but
significant difference between the measures for those cases which entered the clinical
range [(2, N = 17) = 14.59, p < .01].

Table 4.14
Number of Cases Not Crossing Cut-off Scores using Pre- to Post-treatment Data:
CBCL/6-18 Cut-off Score Adjusted from 64 to 60 with BASC-2 ‘At Risk’ Category
Collapsed into Normal Range
Remained Normal

CBCL/6-18

Remained
Clinical
105

6

Total Cases Not
Crossing Cut-off
111

BASC-2

42

47

89

Y-OQ-2.01

108

5

113
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measures in regards to frequencies of cases that remained in the clinical range [(2, N =
255) = 32.68, p < .01], as well as those cases that remained in the normal range [(2, N =
58) = 59.41, p < .01].
This second variation, collapsing three borderline descriptor categories into two,
changed the CBCL/6-18 cut-off score from 64 to 60 while leaving the BASC-2 at risk
borderline descriptor collapsed into the normal range. As can be seen, the BASC-2 has
the greatest number of cases out-performs the CBCL/6-18 and the Y-OQ-2.01 as it did in
the first variation, however the CBCL/6-18 and Y-OQ-2.01 are now performing in
relatively like manner. There is now no statistically significant difference in how the
measures are reporting change for those cases that recovered. These results appear to
support the change in the CBCL/6-18 cut-off score.
A crosstabulation of these pre- to post-treatment cut-off scores for this second
variation yielded 133 valid cases of the 136 in the analytic sample. There was a lower
level of agreement between the measures in this comparison than was seen in the first
variation. Fifty cases (38%) were classified within the same category by all three
measures, with five cases ranked as recovered, 41 cases ranked as remained clinical, and
four cases ranked as remained normal. This comparison reveals there was no agreement
between the three measures regarding the category entered clinical, as was also the case
in the first cut-off score variation.
A third variation in the use of cut-off scores for the CBCL/6-18, BASC-2, and YOQ-2.01 involved collapsing three borderline descriptor categories into two by changing
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Results are presented in Tables 4.15 and 4.16.

Table 4.15
Number of Cases Crossing Cut-off Scores using Pre- to Post-treatment Data: CBCL/6-18
Cut-off Score Adjusted from 64 to 60 and BASC-2 Cut-off Score Adjusted from 70 to 60
Recovered

Entered Clinical

CBCL/6-18

20

3

Total Cases
Crossing Cut-off
23

BASC-2

22

10

32

Y-OQ-2.01

21

1

22

A χ2 analysis, indicated that there was no significant difference between the measures in
regards to frequencies of cases that recovered [(2, N = 63) = 0.1, p = .95]. However, the
measures were still performing differently [(2, N = 14) = 9.57, p < .01] for those cases
that entered the clinical range.
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Number of Cases Not Crossing Cut-off Scores using Pre- to Post-treatment Data:
CBCL/6-18 Cut-off Score Adjusted from 64 to 60 and BASC-2 Cut-off Score Adjusted
from 70 to 60
Remained Normal

CBCL/6-18

Remained
Clinical
105

6

Total Cases Not
Crossing Cut-off
111

BASC-2

94

10

104

Y-OQ-2.01

108

5

113

A χ2analysis, indicated that there was no significant difference between the measures in
regards to frequencies of cases that remained in the clinical range [(2, N = 307) = 1.06, p
= .59] or for those that remained in the normal range [(2, N = 21) = 2, p = .37].
Thus, these results indicated the three measures were performing in like manner
in regards to three categories: recovered, remained clinical, and remained normal. The
measures were only performing differently in one category: entered clinical. These
results were most consistent with expected performance as the standards for cut-off score
determination were equalized to one SD above the mean. Thus, for the purposes of this
study, this variation is considered to be the most appropriate when comparing the
CBCL/6-18, BASC-2, and Y-OQ-2.01 in regards to their performance classifying cases
according to cut-off scores using dichotomous categories. The three measures had
similar number of cases that recovered. The BASC-2 had the greatest number of cases
that entered clinical, showing deterioration, with the CBCL/6-18 and Y-OQ-2.01
showing similar results. The BASC-2 had the least number of cases that remained
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Y-OQ-2.01 showing similar results, though the performance of the BASC-2 is not
statistically different in this category from the other two measures.
A crosstabulation of these pre- to post-treatment cut-off scores for this third cutoff score variation yielded 133 valid cases of the 136 in the analytic sample. Of these,
there was high level of agreement between the measures. Ninety-five cases (71%) were
classified within the same category by all three measures, with eight cases identified as
recovered, one case identified as entered clinical, 83 cases identified as remained
clinical, and three cases identified as remained normal. Thus, the higher level of
agreement indicates that this variation used to demarcate cut-off scores may be the most
appropriate for those seeking to make comparisons between the CBCL/6-18, BASC-2,
and Y-OQ-2.01.
Clinically Significant Change via RCI and Cut-off Scores
Although descriptive for this study’s purpose of examining the manner in which
these three measures evaluate change, cut-off scores are not highly clinically useful alone
(Jacobson & Truax, 1991) due to the “measurement error inherent in the use of such
cutoff points” (p.16). Cut-off scores work in tandem with the pre- to post-treatment RCI
change data in order to evaluate clinically significant change. Each of the three measures
performed differently when evaluating clinically significant change via RCI and cut-off
scores. Those that met the RCI criteria with scores diminishing are referred to as
improved, while those whose scores increased are referred to as deteriorated. Those
participants that had scores fall below a cut-off score are referred to as recovered, while
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clinical. A summary is presented in Table 4.17.

Table 4.17
Number of Cases Classified for Change via RCI Classifications (Improved or
Deteriorated) and Cut-off Score Classifications (Recovered or Entered Clinical) using
Pre- to Post-treatment Data
Deteriorated
&
Entered Clinical
4

Total Cases
Crossing Cut-off

CBCL/6-18

Improved
&
Recovered
27

BASC-2

31

8

39

Y-OQ-2.01

20

1

21

31

Of the 81 cases that the CBCL/6-18 identified as meeting pre- to post-treatment RCI
change criteria, 31 cases crossed the cut-off score of 64. For the 86 cases that met RCI
criteria according to the BASC-2, 39 cases crossed the T-score cut-off of 70. For the 95
cases the Y-OQ-2.01 identified as having met the RCI change criteria, 21 also crossed the
raw score cut-off of 46 (47 for the Y-OQ SR-2.0), thus meeting classification
requirements to be improved and recovered or deteriorated and entered clinical.
As with the original cut-off score comparisons, this clinically significant change
analysis showed that the BASC-2 identified the greatest number of cases showing change
according to the RCI and cut-off score combination, the CBCL/6-18 showed the next
greatest number of cases, and the Y-OQ-2.01 identified the least number of cases.
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significant change as evidenced by the RCI and movement across the cut-off score. This
table includes all cases that reliably improved and those that reliably deteriorated yet did
not cross the cut-off score threshold. It separates cases according to their identification
within the clinical or normal populations: remained clinical and remained normal,
respectively based on their scores from pre- to post-treatment.

Table 4.18
Number of Cases Not Showing Clinically Significant Change via Meeting RCI Criteria
but Not Crossing Cut-off Scores using Pre- to Post-treatment Data
Remained Clinical

Remained Normal

CBCL/6-18

40

10

Total Cases Not
Crossing Cut-off
50

BASC-2

24

22

46

Y-OQ-2.01

70

4

74

According to the CBCL/6-18, 50 cases met RCI change criteria in either
direction; thus they remained in the clinical range from pre- to post-treatment according
to cut-off criteria (i.e., they were reliably changed but not recovered) or remained in the
normal range from pre- to post-treatment (i.e., they were reliably changed but remained
sub-clinical throughout treatment). The BASC-2 identified 46 such cases, while the YOQ-2.01, identified 74. Thus, the BASC-2 had the least number of cases that did not
show clinically significant change and the CBCL/6-18 identified the next least. The YOQ-2.01 had the greatest number of cases that did not show clinically significant change.
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clinically significant change criteria as they are designed to operate. However, as
identified in the cut-off score variations, comparisons using the cut-off scores should be
interpreted with caution due to the differences in criteria among the three measures for
establishing the cut-off scores (Achenbach, 1991, Burlingame et al., 2001, Reynolds &
Kamphaus, 1992, 2004). Yet, by altering the cut-off scores to illustrate consistent
standards for establishing the cut-off score, as was illustrated in the third cut-off score
variation, where the CBCL/6-18 cut-off score was lowered from a T-score of 64 to 60
and the BASC-2 cut-off score was lowered from a T-score of 70 to 60 these comparisons
are more equitable. Using these criteria in another clinically significant change analysis,
the measures evaluated clinically significant change in the following manner, with Table
4.19 and Table 4.20 summarizing the results:

Table 4.19
Number of Cases Showing Clinically Significant Change using Pre- to Post-treatment
Data and Adjusted Cut-off Scores for the CBCL/6-18 and BASC-2
Deteriorated
&
Entered Clinical
3

Total Cases
Crossing Cut-off

CBCL/6-18

Improved
&
Recovered
19

BASC-2

21

8

29

Y-OQ-2.01

20

1

21

21

Table 4.19 shows that of the 81 cases that the CBCL/6-18 identified as meeting pre- to
post-treatment RCI change criteria, 21 cases crossed the adjusted cut-off score of 60,

- 93 meeting classification requirements to be either improved and recovered or deteriorated
and entered clinical. For the 86 cases that met RCI criteria according to the BASC-2, 29
cases crossed the adjusted T-score cut-off of 60. The Y-OQ data remained the same as in
the original analysis; 21 of 95 cases crossed the raw score cut-off of 46 (47 for the Y-OQ
SR-2.0). This clinically significant change analysis showed that the BASC-2 identified
the greatest number of cases showing change according to the RCI and cut-off score
combination, while the CBCL/6-18 and the Y-OQ-2.01 operated in like-fashion.
Table 4.20 indicates the total number of cases that did not show clinically
significant change as evidenced by the RCI and movement across the cut-off score. As
with Table 4.18, this table includes all cases that reliably improved and those that reliably
deteriorated yet did not cross the cut-off score threshold.

Table 4.20
Number of Cases Not Showing Clinically Significant Change via Meeting RCI Criteria
but Not Crossing Cut-off Scores using Pre- to Post-treatment Data and Adjusted Cut-off
Scores for the CBCL/6-18 and BASC-2

Remained Clinical

Remained Normal

CBCL/6-18

54

5

Total Cases Not
Crossing Cut-off
59

BASC-2

54

3

57

Y-OQ-2.01

70

4

74
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the BASC-2 identified 57 such cases; thus they remained in the clinical range from preto post-treatment according to adjusted cut-off score criteria or remained in the normal
range from pre- to post-treatment. The Y-OQ-2.01 data remained as in the original
analysis, classifying 74 cases as unchanged. Thus, with adjusted cut-off score criteria,
the BASC-2 still had the least number of cases that did not show clinically significant
change and the CBCL/6-18 identified the next least. The Y-OQ-2.01 had the greatest
number of cases that did not show clinically significant change.
It appears that when evaluating clinically significant change via RCI and cut-off
scores, as was found in the previous comparison that included the cut-off scores as well
as the original clinically significant change comparison, the BASC-2 is the most sensitive
to change, the CBCL/6-18 has the next greatest sensitivity to change, and the Y-OQ-2.01
has the least sensitivity to change. Since there was no statistical difference between the
cut-off score findings for the three measures, these results for clinically significant
change should be interpreted with caution.
HLM Analyses with Time Variable
Change was lastly examined through HLM inferential statistical methods for three
major comparisons: adult comparison, adult and adolescent dyad comparison, and
adolescent comparison.
Adult Informant Comparison
The first HLM comparison involved only the parent-report versions of the
CBCL/6-18, BASC-2, and Y-OQ-2.01. Therefore the first analytic model was tested
omitting the I variable representing informant, which produced the following analytic

- 95 model: Y = O + M + O * M + log(D) + O * log(D) + M * log(D) + O * M * log(D). Initial YOQ-2.01 scores and age at intake were covariates in the analysis, and remained as such in
all subsequent analyses. Results as measured by the 134 parents or significant-adult
figures in the analytic sample are presented in Table 4.21.

Table 4.21
134 Adult Informant Cases: F values and Significance Levels
Effect

Num

Den

F Value

Significance

DF

DF

Initial Y-OQ-2.01

1

265

506.33

< .01

Age At Intake

1

265

6.66

.01

Outcome (O)

1

265

6.39

.01

Measure (M)

3

265

63.89

< .01

Outcome * Measure (O * M)

2

265

12.02

< .01

Logdays (log(D))

1

132

82.09

< .01

Outcome * Logdays (O * log(D))

1

265

49.81

< .01

Measure * Logdays (M * log(D))

2

253

14.68

< .01

Outcome * Measure * Logdays

2

265

11.82

< .01

Level

(O * M * log(D))

The covariates, initial Y-OQ-2.01 and child’s age at intake were both significant
in this analysis (p < .01 and p = .01, respectively), which indicated their significance in
the analysis; results were different for those with more extreme intake scores and those of
differing ages. For this adult informant comparison, every element within the analytic
model produced significant results. Element O in the analytic model represented
outcome, which was classified into two groups: improved and deteriorated. These labels
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established previously. If the final Y-OQ-2.01 score decreased they were classified as
improved, while if the score increased they were classified as deteriorated. Results
indicated a significant difference relative to outcome (p = .01), indicating there was a
difference between those who improved and deteriorated, averaged across the three
measures.
As an explanatory note, these classifications included both those that met pre- to
post-treatment RCI criteria and those that showed RCI change at some point during the
study but did not meet RCI criteria for pre- to post-treatment. For example, over a 2month period, Case #230 showed non-RCI changes, yet when filling out the fifth data
collection point the mother reported to a research assistant that her daughter was
currently in a suicidal crisis. Her Y-OQ-2.01 converted T-scores reflect this (65, 69, 56,
63, and 90) and provide illustration for scores that met pre- to post-treatment RCI criteria.
Over a 7-month period, Case #204 showed RCI changes between various data collection
points, but the change between the initial Y-OQ-2.01 and the final Y-OQ-2.01 did not
meet RCI criteria. His converted T-scores illustrated this (74, 81, 60, 95, and 77) and
provide an example of scores that met RCI criteria at some point in the study but not for
pre- to post-treatment.
Results were significant between the intercepts of the three different instruments
or measures (p < .01), as indicated by the M element of the statistical model, though the
difference in slopes, rather than intercepts, is the primary focus of this study. The twoway interaction of M * O was also significant, indicating an interaction between method
of measurement and the therapeutic outcome of the child or adolescent. This indicates
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change. The CBCL/6-18 was significantly different from the Y-OQ-2.01 (p < .01). The
BASC-2 was also significantly different from the Y-OQ-2.01 (p = .01). A t-test on the
pair-wise test of differences indicated that the CBCL/6-18 and the BASC-2 were not
significantly different from each other (p = .36). The element log(D) in the analytic model
was also significant (p < .01).
The interaction of outcome by time (O * log(D)) was significant (p < .01), as well
as the interaction of the measures and time (M * log(D); p < .01). Again, however, in the
pair-wise test of differences, the CBCL/6-18 and the BASC-2 were not significantly
different from each other (p = .73). These findings are best described by the significant
three-way interaction of outcome (improved or deteriorated), measures (the CBCL/6-18,
BASC-2, and Y-OQ-2.01), and time (O * M * log(D); p < .01) in which CBCL/6-18 and
the BASC-2 were not significantly different from each other (p = .55). Slopes that
resulted from this interaction, as measured by the 134 adults in the analytic sample are
presented in Table 4.22. The SAS 9.1 estimates from the final analytic models were
combined to calculate these slopes. Negative slopes indicate that the measures showed a
reduction of negative symptoms and behaviors (i.e. the child or adolescent had improved
as reported by the parents); while a positive slope indicates the measures showed an
increase of negative symptoms and behaviors, indicating the child or adolescent had
deteriorated.
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Slopes for CBCL/6-18, BASC-2, and Y-OQ-2.01 from 134 Adult Informants, Relative to
Outcome
Improved

Deteriorated

CBCL/6-18

-1.02

0.35

BASC-2

-1.11

0.57

Y-OQ-2.01

-2.3

1.39

The slopes produced by the CBCL/6-18 and BASC-2 relative to therapeutic outcome
(improved, n = 99, and deteriorated, n=35) averaged across days are significantly
different from the slopes produced by the Y-OQ-2.01 relative to outcome averaged across
days. The Y-OQ-2.01 slope for improved (m = -2.23) was 2 and 2.19 times steeper than
the corresponding slopes for the CBCL/6-18 and the BASC-2 (m = -1.11 and -1.02,
respectively). The Y-OQ-2.01 slope for deteriorated (m = 1.39) was 3.97 and 2.44 times
greater than the slopes for the corresponding classifications of the CBCL/6-18 and
BASC-2 (m = 0.35 and 0.57, respectively). The slope of the BASC-2 was steeper than
the slope of the CBCL/6-18 in both improved and deteriorated classifications, but they
were not statistically different.
HLM slopes are represented graphically with the following considerations. The
statistical model calculates change via days, yet for graphical necessity days have been
grouped within weeks. For representation purposes, the graphs represent change slopes
up to 259 days (37 weeks). There were 7 participants that were followed beyond that

- 99 period; 381 days (1.04 years) was the longest span of time a participant remained in the
study.
Figure 4.1 presents these findings graphically for those cases where the child or
adolescent had an improved outcome.
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Figure 4.1 Slopes for the CBCL/6-18, BASC-2, and Y-OQ-2.01 calculated from
99 adult informants, relative to children or adolescents with an improved
outcome.

As shown, the Y-OQ-2.01 was most sensitive to symptom distress at intake and showed
the steepest slope. Although a difference appears in the BASC-2 and CBCL/6-18 slopes,
there is no statistical difference and graphically there appears to be little practical
difference as they follow an almost parallel course with approximately one T-score

- 100 between them. The CBCL/6-18 reported the lowest levels of distress throughout the
entire course of change. Figure 4.2 presents these findings graphically for 35 cases where
the child or adolescent had a deteriorated outcome.
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Figure 4.2 Slopes for the CBCL/6-18, BASC-2, and Y-OQ-2.01 calculated from
35 adult informants, relative to children or adolescents with a deteriorated
outcome.

As presented in Table 4.16 and Figure 4.2, the slope of the CBCL/6-18 for those
that deteriorated was 0.35 while the slope of the BASC-2 was 0.57, representing an
average shift of approximately two and three T-score points, respectively. The slope of
the Y-OQ-2.01 equaled 1.39, representing an average shift of approximately seven Tscore points. Although the average deterioration shown by each of these measures did
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CBCL/6-18 and BASC-2 indicates that for a client that begins to show signs of
deterioration through increasing scores, a clinician would best be able to detect those
changes quickly by using the Y-OQ-2.01.
Adult and Adolescent Dyad Comparison
The first analytic model was also examined with the informant variable in place to
examine any differences between the parent- and self-report versions of the measures: Y
= O + M + O * M + I + O * I + M * I + O * M * I + log(D) + O * log(D) + M * log(D) + O *
M * log(D) + I * log(D) + M * I * log(D) + O * I * log(D) + O * M * I * log(D). Forty-two of
the 44 adolescent informants of the analytic sample had a corresponding significant-adult
figure who also served as an informant. Results as measured by these adult and
adolescent dyads are presented in Table 4.23.
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42 Adult and Adolescent Informant Dyad Comparisons: F values and Significance Levels
Effect

Num

Den

F Value

Significance

DF

DF

Initial Y-OQ-2.01

1

156

29.99

< .01

Age At Intake

1

156

1.53

.22

Outcome (O)

1

156

3.19

.08

Measure (M)

2

156

41.32

< .01

Outcome * Measure (O * M)

2

156

4.61

.01

Informant (I)

1

156

14.33

<.01

Outcome * Informant (O * I)

1

154

1.05

.31+

Measure * Informant (M * I)

2

156

18.21

< .01

Outcome * Measure *

2

154

2.54

.08+

Logdays (log(D))

1

76

39.81

< .01

Outcome * Logdays (O * log(D))

1

156

16.90

< .01

Measure * Logdays (M * log(D))

2

147

6.94

< .01

Outcome * Measure * Logdays

2

156

3.48

< .05

Informant * Logdays (I * log(D))

1

156

3.37

.07

Measure * Informant * Logdays

2

154

0.44

.64+

1

156

4.23

< .05

2

154

1.96

.15+

Levels

Informant (O * M * I)

(O * M * log(D))

(M * I * log(D))
Outcome * Informant * Logdays
(O * I * log(D))
Outcome * Measure *
Informant * Logdays
(O * M * I * log(D))
( + ) denotes this element was dropped from the final model.
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the restricted range of ages (e.g., only ages 12 and above) included in this comparison.
Outcome alone was not significant (O; p = .08); this may be due to the reduced sample
size from the sample size that was used in the adult informant analysis. The CBCL/6-18,
BASC-2, and Y-OQ-2.01 each performed significantly differently (M; p < .01), and did
so also when the measures interacted with outcome (O* M; p = .01). Informant was
significant in this model (I; p < .01) indicating there was a difference between the intake
scores, or intercepts, of parent- and self-report informants. O * I, the interaction between
outcome and informant, was not significant (p = .31) and was dropped from the final
model. The interaction between informant and measure was significant (M * I; p < .01)
indicating the parent- and self-report versions of the measures were performing
differently. The interaction of outcome, measure, and informant was not significant (O *
M * I; p = 0.08) and was dropped from the final model.
The time element, log(D), was significant (p < .01), as were the interactions of
outcome by time (O* log(D); p = < .01), and measure by time (M * log(D); p < .01). Thus,
the interaction of outcome by measure by time (O * M * log(D)) was also significant (p <
.05) indicating that when averaged across time and outcome the measures performed
differently. Each measure will be illustrated in turn respective to this interaction. The
interaction of informant by time (I * log(D)) was not significant (p = .07), nor was the
measure by informant by time interaction (M * I * log(D); p = .64) and due its high p
value it was dropped from the final model. The outcome by informant by time
interaction was significant (O * I * log(D); p < .05). The four-way interaction of outcome
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dropped from the final model due to its high value.
Table 4.24 and Table 4.25 present the slopes for adult and adolescent informant
dyads, 33 of whom improved and nine of whom deteriorated, respectively.

Table 4.24
Slopes for CBCL/6-18, BASC-2, and Y-OQ-2.01 from 33 Adult and Adolescent Dyads
Relative to an Improved Outcome
Adult

Adolescent

CBCL/6-18

-1.25

-0.49

BASC-2

-1.43

-0.66

Y-OQ-2.01

-2.42

-1.65

Table 4.25
Slopes for CBCL/6-18, BASC-2, and Y-OQ-2.01 from 9 Adult and Adolescent Dyads
Relative to a Deteriorated Outcome
Adult

Adolescent

CBCL/6-18

0.8

-0.2

BASC-2

0.85

-0.15

Y-OQ-2.01

1.27

0.26

Figure 4.3 presents the CBCL/6-18 Youth Self-Report (YSR) slopes compared to
those from their corresponding adult-figure CBCL/6-18 forms, calculated from 33

- 105 adolescent informants, relative to an improved outcome. The CBCL/6-18 adult
informants produced a slope of -1.25, 2.55 times greater than the slope of -0.49 produced
by the adolescent informants.
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Figure 4.3 The CBCL/6-18 Youth Self-Report (YSR) slopes compared to those
from their corresponding adult CBCL/6-18 forms, calculated from 33 adult and
adolescent informant dyads, relative to an improved outcome.

As can be seen, the CBCL/6-18 adult form is more sensitive to change throughout
the treatment process, representing higher levels of distress at intake, as well as lower
levels of distress at the 37 week mark. Thus, it would be recommended that clinician’s
select the parent-report of the CBCL/6-18 over the YSR if data from only one informant
can be obtained.
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those from their corresponding adult CBCL/6-18 forms, calculated from nine adult and
adolescent informant dyads, relative to a deteriorated outcome as previously established
by the Y-OQ-2.01. As presented in Table 4.25, the CBCL/6-18 adult informants
produced a slope of 0.8, 6 times that of the slope produced by the adolescent informants
(m = -0.2). The adolescents represented themselves as slightly improved while their
parent or significant-adult figure showed deterioration of approximately four T-score
points.
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Figure 4.4 The CBCL/6-18 Youth Self-Report (YSR) slopes compared to those
from their corresponding adult CBCL/6-18 forms, calculated from nine adult and
adolescent informant dyads, relative to a deteriorated outcome.

- 107 Figure 4.5 presents the BASC Self-Report of Personality (SRP) slopes compared
to those from their corresponding adult BASC-PRS-A forms, calculated from 33 adult
and adolescent informant dyads, relative to an improved outcome. As presented in Table
4.24, the BASC-2 adult informants produced a slope of -1.43, 2.17 times greater than the
slope of -0.66 produced by the adolescent informants. As can be seen graphically,
adolescents report their distress at a lower level than do their corresponding adult
informants.
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Figure 4.5 The BASC-2 Self-Report of Personality (SRP) slopes compared to
those from their corresponding adult-figure BASC-PRS-A forms, calculated from
33 adolescent informants, relative to an improved outcome.

- 108 Figure 4.6 presents the BASC Self-Report of Personality (SRP) slopes compared
to those from their corresponding adult BASC-PRS-A forms, calculated from nine adult
and adolescent informant dyads, relative to a deteriorated outcome. The BASC-2 adult
informants produced a slope of 0.85, 5.66 times greater than the slope of -0.15 produced
by the adolescent informants, as presented in Table 4.25. In addition to a large
discrepancy in rate of change as illustrated by these differences in slope, as can be seen
graphically, adolescents report their distress by week eight an average of 13 T-score
points lower than do their corresponding adult informants.
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Figure 4.6 The BASC-2 Self-Report of Personality (SRP) slopes compared to
those from their corresponding adult-figure BASC-PRS-A forms, calculated from
9 adolescent informants, relative to a deteriorated outcome.

- 109 Figure 4.7 presents the Y-OQ SR-2.0 slopes compared to those from their
corresponding adult- Y-OQ-2.01 forms, calculated from 33 adult and adolescent
informant dyads, relative to an improved outcome. The Y-OQ-2.01 adult informants
produced a slope of -2.42, 1.47 times greater than the slope of -1.65 produced by the
adolescent informants. As can be seen, adolescents report their distress at lower levels
than do their corresponding adults.
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Figure 4.7 The Y-OQ SR-2.0 slopes compared to those from their corresponding
adult-figure Y-OQ-2.01 forms, calculated from 33 adolescent informants, relative
to an improved outcome.

Figure 4.8 presents the Y-OQ SR-2.0 slopes compared to those from their
corresponding adult Y-OQ-2.01 forms, calculated from nine adult and adolescent

- 110 informant dyads, relative to a deteriorated outcome. The Y-OQ-2.01 adult informants
produced a slope of 1.27, 4.88 times greater compared than the slope of 0.26 produced by
the adolescent informants. This discrepancy among the slopes of youth and parent
informants for the Y-OQ-2.01 is substantial, indicating that the Y-OQ SR-2.0 is not
detecting client deterioration as is the Y-OQ-2.01.
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Figure 4.8 The Y-OQ SR-2.0 slopes compared to those from their corresponding
adult-figure Y-OQ-2.01 forms, calculated from nine adolescent informants,
relative to a deteriorated outcome.

Adolescent Informant Comparison
The analytic sample of 136 contained 44 adolescent informants that participated
in the study; this sample contained 19 males and 25 females. Thirty-five of these

- 111 adolescents were classified by the Y-OQ-2.01 pre- to post-treatment change as improved,
while nine were classified as deteriorated. Results of a comparison between the slopes of
the CBCL/6-18 YSR, BASC-2-SRP, and Y-OQ SR-2.0 as measured by these 44 youth
are presented in Table 4.26.

Table 4.26
44 Adolescent Informant Cases: F values and Significance Levels
Effect

Num

Den

F Value

Significance

DF

DF

Initial Y-OQ-2.01

1

85

1.84

.18

Age At Intake

1

85

3.35

.07

Outcome (O)

1

85

2.79

.09

Measure (M)

3

85

6.11

< .01

Outcome * Measure (O * M)

2

85

0.31

.74

Logdays (log(D))

1

43

7.85

< .01

Outcome * Logdays (O * log(D))

1

85

2.58

.11

Measure * Logdays (M * log(D))

2

83

1.30

.28

Outcome * Measure * Logdays *

2

85

0.27

.77

Level

(O * M * log(D))

For this adolescent informant comparison, the covariates of initial score and age
were not significant (p = 0.18; p = 0.07, respectively). Element O of the analytic model,
based on adolescent outcome classification, did not produce significant results (p = 0.09).
The M element, representing type of measure, was significant (p < .01), indicating the
intercepts of the measures were different. The element log(D) in the analytic model was
also significant (p < .01), indicating adolescents made progress as they continued through
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indicating the therapeutic progress reported by adolescents was not different relative to
instrument. Thus, the CBCL/6-18 YSR, BASC-2-PRS, and Y-OQ SR-2.0 were not
distinguishable relative to sensitivity to change in the adolescent-only sample.
Although no significance was found for the three-way interaction of outcome,
measures, and time (O * M * log(D)), indicating no significant differences between how
the measures performed in tracking changes over time for adolescent self-informants,
since the results for those that improved are consistent with the findings of the adult
informant comparison as well as for the adult and adolescent dyad comparison, the tables
and figures for this comparison are included for descriptive illustration. Table 4.27
provides the slopes for the CBCL/6-18 YSR, BASC-2-SRP, and Y-OQ SR-2.0 from 44
adolescent informants, relative to outcome.

Table 4.27
Slopes for CBCL/6-18 YSR, BASC-2-SRP, and Y-OQ SR-2.0 from 44 Adolescent
Informants, Relative to Outcome (Based on Non-significant Results)
Improved

Deteriorated

CBCL/6-18 YSR

-0.43

0.2

BASC-2 SRP

-0.82

0.03

Y-OQ SR-2.0

-1.32

0.08

- 113 As seen in Table 4.27, although not statistically significant in this analytic comparison,
the slopes produced by the Y-OQ SR-2.0 (m = -1.32) relative to an improved therapeutic
outcome (improved, n = 35) was steeper by 3.06 and 1.61 times than the slopes for the
corresponding classifications of the CBCL/6-18 and BASC-2 (m = -0.43 and -0.82,
respectively). The slope of the BASC-2 is steeper than the slope of the CBCL/6-18 by
1.91 times for those that improved.
Figure 4.9 presents these findings graphically for those 35 youth that were
classified as improved. The slopes in this figure are similar to those in the adult
informant and adult and adolescent dyad analyses. However, statistical significance was
not reached.
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Figure 4.9 Slopes for the CBCL/6-18 YSR, BASC-2-SRP, and Y-OQ SR-2.0
calculated from 35 adolescent informants, relative to those with an improved
outcome.

Figure 4.10 presents these non-significant findings graphically for those nine youth
classified as deteriorated. Relative to a deteriorated therapeutic outcome (deteriorated, n
= 9) the slope of the CBCL/6-18 (m = 0.2) is steeper than the slope of the BASC-2 (m =
0.03) and the slope of the Y-OQ-2.01 (m = 0.08) by 6.66 and 2.5 times, respectively.
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Figure 4.10 Slopes for the CBCL/6-18 YSR, BASC-2-SRP, and Y-OQ SR-2.0
calculated from 9 adolescent informants, relative to those with a deteriorated
outcome.
HLM Analyses with Dosage Variable
The second analytic model for HLM analyses was as follows: Y = O + M + O *
M + I +M * I + O * M * I + log(V) + O * log(V) + M * log(V) + O * M * log(V) + I * log(V) +
M * I * log(V) + O * M * I * log(V) with V equal to session or therapeutic contact number
(intake counts as session one) in order to also track dose of therapy. This model is the
same as the first analytic model, only with session number substituted for the time
variable. One outlier was excluded from theses analyses due to an excessive number of
sessions (Case #138 had 110 therapeutic services during his tenure in the study while the
range of all other cases was 1-48 sessions). Therefore, the sample for the adult informant
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and the adolescent informant analysis contained 41 cases. HLM results regarding
sensitivity to change for the CBCL/6-18, BASC-2, and Y-OQ-2.01 using the session
variable showed statistical significance in identical model elements and interactions at
approximately the same levels to those from the first model using the time variable,
indicating no significant statistical differences between the two models. Thus, it appears
that session number and time are surrogates for each other in this study. Furthermore, the
analyses using days in treatment as the time variable were emphasized given previous
literature that found no dose-effect relationship (Salzer, Bickman, & Lambert, 1999) or
even a “reverse dose-effect trend” when dose was defined solely by the number of
sessions attended (Reardon, Cukrowicz, Reeves, & Joiner, 2002, p. 280).
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Discussion
This study examined the relative sensitivity to change of the CBCL/6-18, BASC2, and Y-OQ-2.01 parent- and self-report versions. Using the CBCL/6-18 and BASC-2,
measures that were not designed for tracking change and that are less change sensitive,
for tracking change is potentially problematic since their consumers attempt to assess the
quality of treatments and calibrate the needs of individual clients based on the data these
measures produce. Though these measures are the standards in the fields for which they
were created (i.e., assigning diagnoses), the adopted use of tracking treatment and
outcome is discouraged based on the results of this study. Significant differences found
between these measures and the Y-OQ-2.01 regarding sensitivity to change allow the
work of researchers, clinicians, and health care corporations to be maximized by
discontinuing the use of the CBCL/6-18 and BASC-2 as tracking instruments in favor of
the Y-OQ-2.01.
Change was examined through the use of the reliable change index (RCI), cut-off
scores, and hierarchical linear modeling (HLM) slopes. Overall, the results across RCI
and HLM analytical methods confirmed the study hypothesis that the parent-report
version of the Y-OQ-2.01 was more sensitive to change over time and session number
than the BASC-2. Yet, the hypothesis that the CBCL/6-18 was less sensitive to change
over time and session number than the BASC-2 or Y-OQ-2.01 parent-report versions was
not confirmed in this study. Cut-off score analyses indicated there were no statistically
significant differences between the three measures in the manner in which they classified
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the BASC-2.
Though these analyses created a landscape of average change results by
examining the study’s sample on a nomothetic level, it should be noted that these average
changes are of import only in that they represent the idiographic changes the measures
captured; these measures document change in severity of, and frequency of,
psychopathological symptoms on an individual, per-client basis. The sensitivity with
which these measures capture change, and the manner in which the changes are then
acknowledged and incorporated into treatment by researchers, clinicians, and health care
corporations, may have significant impact on the course of therapy and eventual
therapeutic outcome for each child and adolescent seeking psychotherapeutic services.
The hypothesis that this pattern of change sensitivity would also be found for the
self-report versions of the measures was not confirmed in this study; although trends
were similar to those seen in the adult informant comparison, results were not statistically
significant.
This chapter highlights these important findings and their implications for the
clinical treatment of children and adolescents seeking psychotherapeutic services. This
chapter also briefly discusses limitations concurrently with recommendations for future
research.
Major Findings and Implications
The CBCL/6-18, BASC-2, and Y-OQ-2.01 were compared relative to nine
characteristics identified by researchers and clinicians to aid consumers in choosing an
ideal outcome measure:
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Weber, 1997);
2. Excellent validity, including validity for change (Lambert & Hill, 1994;
Lipsey, 1990; Vermillion & Pfeiffer, 1993; Weber, 1997);
3. Sensitivity to change (Achenbach & Rescorla, 2004; Lambert & Hill, 1994;
Vermillion & Pfeiffer, 1993);
4. Normed, with use of score cut-off scores and RCI norms (Durlak et al., 1995;
Jacobson et al., 1984; Jacobson & Truax, 1991; Vermillion & Pfeiffer, 1993);
5. Brief; to be completed quickly (Burlingame et al., 1995; Lambert & Hill,
1994; Kazdin, 2005; Lipsey, 1990; Hatfield & Ogles, 2004);
6. Scored and interpreted easily and quickly (Burlingame at al., 1995; Kazdin,
2005; Lambert & Hill, 1994, Hatfield & Ogles, 2004);
7. Relevant client information regarding change provided (e.g., Lambert & Hill,
1994; Vermillion & Pfeiffer, 1993);
8. Can be used frequently to track progress (i.e., more than two data points; Bryk
& Raudenbush, 1987; Bryk & Weisberg, 1977; Burlingame et al., 1995;
Hatfield & Ogles, 2004; Kazdin, 2005; Rogosa et al., 1982);
9. Cost efficient (Burlingame et al., 1995; Hatfield & Ogles, 2004; Weber 1997).
As shown in Table 2.1, adequate information was available to compare the
measures in seven of these nine characteristics from the extant literature. Each had
excellent reliability and validity, including validity for change. The Y-OQ-2.01 is the
shortest of the measures, with the others taking at least twice the time for clients to
complete. Scoring appears to be relatively identical, as all use computer scoring
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though these domains vary depending on the purposes for which the measures were
designed. The Y-OQ-2.01 is designed to be used the most frequently and is the most
cost-effective. If each of these seven characteristics were considered equal, the Y-OQ2.01 appears to be the better choice for use as an outcome measure, regarding its brevity,
ability for frequent use, and cost. To complete the comparison between the measures in
regards to the recommended characteristics of outcome measures, this study focused on
sensitivity to change and the use of cut-off scores and RCI.
HLM Change Slopes for the CBCL/6-18, BASC-2, and Y-OQ-2.01 Illustrating Sensitivity
to Change
The CBCL/6-18, BASC-2, and Y-OQ-2.01 performed differently relative to their
sensitivity to changes that occurred in children and adolescents receiving outpatient
psychotherapeutic services from Valley Mental Health, a community clinic. The most
significant findings in this study were produced through the HLM analyses evaluating the
parent-report versions of the CBCL/6-18, BASC-2, and Y-OQ-2.01 with a time variable
and a session or dosage variable. These analyses produced change slopes that illustrated
differential sensitivity to change; the Y-OQ-2.01 was most change sensitive, while the
BASC-2 and the CBCL/6-18 were not statistically different from each other.
The Y-OQ-2.01 was “designed cooperatively by clinicians, researchers, and
managed care administrators in order to meet the needs of all three” (Burlingame et al.,
2001, p. 361). The Y-OQ-2.01 satisfies the recommendations previous researchers have
suggested for outcome measures; indeed, it was presented by Kazdin (2005) as an
illustration for a child and adolescent measurement option. In addition, the Y-OQ-2.01

- 121 showed the greatest sensitivity to change relative to the BASC-2 and CBCL/6-18 using
RCI analyses and HLM change slopes. In RCI analyses that included examinations of
RCI change at any point in treatment and RCI change pre- to post-treatment, the Y-OQ2.01 identified the most cases as showing reliable change in both analyses, followed by
the BASC-2 and CBCL/6-18 respectively. In the HLM analyses, change slopes for the
134 adult informants using the days in treatment, or time, variable, indicated that the YOQ-2.01 slope for cases that improved, was more than two times steeper than the slopes
for the corresponding classification of the BASC-2 and CBCL/6-18. In the adolescent
informant comparison the interactions were non-significant, yet the HLM slopes for 35
cases that improved are consistent with the findings of the adult informant comparison
suggesting that the Y-OQ SR-2.0 may be more sensitive to change than the BASC-2-PRS
and the CBCL/6-18 YSR. This finding regarding improved cases is substantial and has
implications for researchers, clinicians, and managed care administrators by showing the
Y-OQ-2.01 has the change sensitivity to answer the questions relevant to their domain.
Current issues, such as efforts to establish or work within session limits or evaluate
progress and final outcome of treatment, can be facilitated by using the measure with the
greatest established change sensitivity.
Perhaps the most important finding, relative to its potential impact on the
therapeutic outcome of the client, is the manner in which the measures performed relative
to clients that showed an increase in symptoms. The Y-OQ-2.01 slope for cases that
deteriorated was 3.97 and 2.44 times steeper than the slopes for the CBCL/6-18 and
BASC-2, respectively. The intercepts of the three measures for those that deteriorated
were similar; yet within an average of the first three to five weeks, the Y-OQ-2.01
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time. Thus, using the Y-OQ-2.01 would allow therapists to detect deterioration early
which may serve to prevent treatment failure or identify potentially harmful treatments
(Lambert, 2007; Lilienfeld, 2007).
Evidence for the manner in which the Y-OQ SR-2.0 detects deterioration is not
compelling in this study. In the adolescent informant comparison, the slopes for the nine
cases that deteriorated indicated the Y-OQ SR-2.0 slope was the steepest of the three
measures, followed by the CBCL/6-18 YSR and the BASC-2-SRP. Due to the relatively
flat slopes and non-significant results these results should not be interpreted alone;
however, they are presented in support of the general findings.
When the HLM analytic comparisons were replicated using the therapeutic
dosage or session variable results were identical in statistical significance levels to those
results from the analytic comparisons using the time variable. Thus, the findings of the
HLM analyses have supported the first hypothesis of this study. It is recommended that
clinicians select the Y-OQ-2.01 over use of the BASC-2 or CBCL/6-18 as an outcome
measure or for tracking client changes in child and adolescent symptoms and behaviors.
The adult and adolescent dyad comparison results were done to further examine
which informant produced results that were most sensitive to change. Results of this
comparison indicated that the informant variable was significant. In every comparison,
the adult informants produced a higher intercept than did the adolescent informants. The
interaction between informant and measure was also significant, indicating the parentand self-report versions of the measures were performing differently as they tracked
change. HLM slopes for the CBCL/6-18, BASC-2, and Y-OQ-2.01 for both improved
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Thus, the parent versions of these measures are more sensitive to change throughout the
treatment process and are recommended for use over the self-report versions of the
measures when data from only one informant can be obtained or when considering
policy. The discrepant results in the parent versus youth self-report analyses suggest that
the self-report measures (the CBCL/6-18 YSR, BASC-2-SRP, and Y-OQ SR-2.0) did not
operate as parallel forms to the parent versions, that the adolescent data contained greater
variability, or that the adolescent informant sample size was not large enough to detect
significance differences in the slopes.
The CBCL/6-18, BASC-2, and Y-OQ-2.01 as Screening Instruments for Reliable Change
When evaluating sensitivity to change based on RCI criteria for study inclusion,
(i.e., reliable change at any point in treatment) the Y-OQ-2.01 identified the greatest
number of cases as having met the criteria for reliable change, followed by the BASC-2
and the CBCL/6-18. A purer test of whether reliable change had occurred defined cases
for which at least two of the measures indicated RCI criteria was satisfied. At this
stringency, the Y-OQ-2.01 identified the least number of cases, followed by the BASC-2,
and the CBCL/6-18, that showed no reliable change but were identified as meeting
reliable change criteria by the other two measures. Relative to screening cases for
meeting RCI criteria pre- to post-treatment, the results were consistent. According to
these findings the Y-OQ-2.01 would be the first choice for selecting an outcome measure,
followed by the BASC-2 and CBCL/6-18.
Identifying reliable change is important because the RCI establishes a confidenceinterval based on error variance that must be exceeded in order to label a client’s change
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depiction of client change due to its higher sensitivity. Thus, consumers will make clientcare decisions based on actual change in functioning rather than change that occurred due
to error or daily fluctuations in mood/functioning. This finding supports the findings of
the HLM analyses. Thus, the Y-OQ-2.01’s sensitivity to change can aid researchers in
their attempts to make more refined inquires to advance the current literature, such as in
attempts to identify a dose-effect relationship (Reardon et al., 2002).
The CBCL/6-18, BASC-2, and Y-OQ-2.01 as Outcome Measures for Clinically
Significant Change
In examining clinically significant change—which includes meeting RCI criteria
and crossing the cut-off score into the normal range—the results indicated the BASC-2
recognized the greatest number of cases as improved and recovered, followed by the
CBCL/6-18, and the Y-OQ-2.01. This ordering remained consistent for those that
deteriorated and entered clinical and for cases showing no movement across the cut-off
threshold.
Since the criteria used to establish the cut-off scores for the various measures
were dissimilar (Achenbach, 1991, Burlingame et al., 2001, Reynolds & Kamphaus,
1992, 2004) cut-off scores were adjusted to one SD above the mean. With these
adjustments, the same ordering of the measures was found, yet in regards to the cut-off
score analysis the performance of the BASC-2 was not statistically different from others,
thus this finding should be interpreted with caution. In addition, this finding is not
consistent with the general findings of this study regarding the measures’ relative
sensitivity to change, as established by the RCI and HLM. It is suggested that the HLM
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performance of the CBCL/6-18, BASC-2, and Y-OQ-2.01 in tracking changes in clients.
Limitations and Recommendations
VMH is a community-based outpatient child and adolescent clinic that generally
serves those with lower incomes, including those who are on the United States health
program Medicaid. Within this naturalistic setting, treatment method and treatment
length were not altered in any way for the purposes of this study. Data collection
involved gathering repeated data measures, up to five times for each participant; 548 data
points were obtained from 178 participants. Thus, external validity is strong for the
findings and implications. Yet, there are four main limitations that elicit
recommendations for future research in this area.
The first limitation of this study is generalizability. This population was not a
random sample and was limited to those attending VMH in Salt Lake City, UT.
Although findings may likely be generalized to other community clinics in the United
State due to the general nature of community clinics and the workings of the federal
Medicaid program, caution should be used in generalizing results to those who may be
from more diverse cultures or countries. Findings should not be generalized for
populations which were not included in this study, such as chronic inpatients, those in
acute care facilities, or normal populations.
A second limitation is sample size. Although statistical significance was achieved
for the adult informants with the sample size obtained, there were only a small number of
cases that were shown to deteriorate. Outcome was taken into account within the
statistical model to statistically utilize degrees of freedom for the entire sample, yet the

- 126 individual graphs of deterioration were based on relatively small numbers and may lack
the sensitivity of the graphs based on larger numbers. In addition, since significance was
not achieved with the adolescent informant sample, yet the results followed similar trends
found in the statistically significant comparisons, it is possible that the adolescent
informant sample size was not large enough to detect significant interactions among these
observed differences, there may be greater variability in the data, or the self-report
measures do not track changes as do the adult forms.
Third, the omission of a control group is a significant limitation. The original
study was conceived with a control group consisting of those clients that had gone
through intake, agreed to participate in the study, did not return for therapy after that first
session at VMH, and yet followed through by returning additional measures for
additional data points completed through the mail. However, due to the number of
participants recruited, this was not realized. In this study researchers attempted to contact
all participants via mail that did not return to VMH, or that were unable to meet research
assistants personally at VMH to fill out measures. There were 32 cases from which
researchers were able to obtain completed measures via mail; 28 of these cases were
retained in the analytic sample due to RCI criteria and none of these cases met the
requirements for the control group (i.e., they all had continued services beyond intake).
This limitation does not allow confidence in the conclusions that the change observed in
this study was achieved due to psychotherapeutic intervention, as was originally
conceived. Instead, sensitivity to change results have been explored in a more general
sense, without claim that psychotherapy was the mechanism of the observed changes.
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VMH intake procedures in any way. Thus, the Y-OQ-2.01 was given prior to meeting
with a therapist, while the CBCL/6-18 and BASC-2 were given afterwards when clients
who chose to become study participants returned to the intake room to fill out
consent/assent forms and complete the other measures. Future researchers should attempt
to control for this limitation by assuring all measures are completed without interruption.
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- 143 APPENDIX A: MAILING LETTER

Dear Parent:
We appreciate your participation in our research study at Valley Mental Health. We have
not been able to connect with you to fill out the next set of measures. Whether or not you
are still receiving services at Valley Mental Health, we invite you to continue to
participate in our study.
We have included a self-addressed, stamped envelope, as well as a gift certificate as a
“Thank You” for your time and participation.
This is all you have to do:
1) Complete the enclosed forms
2) If your child is over 12, and is participating in the study, please have them
complete their set that has the SRP-A (blue) and the tan questionnaire
3) Return all the completed forms in the self-addressed stamped envelope
4) Enjoy the enclosed gift certificate (2 are included if your child is over 12 and
also participating)
Thank you in advance for your participation! This study will provide valuable
information to aid therapists that treat children and adolescents. If you have any
questions, please call Debra Theobald McClendon at [phone number included here] or
email at [email address included here].
Sincerely,

Debra Theobald McClendon, MA
CEPICA Research Group
Brigham Young University

- 144 APPENDIX B: TEST TAKING SURVEY

TEST TAKING SURVEY
Study ID# __________

Please circle one:

Parent/Guardian

Youth

Please respond to the following 10 questions by circling the answer that best describes
your experience filling out the measures over the course of this study. We are interested
in how you really felt about filling out the same measures a number of times. For
example, did you get bored, did you not mind doing it, did you feel you observed
behavior more carefully, etc. Please use the following scale:
N=Never

R=Rarely

S=Sometimes

F=Frequently

1. I carefully completed the test each time I took it.

AA=Almost Always
1 2 3 4 5
N R S F AA

2. I got tired of taking the test and just marked the answers.

N R S F AA

3. I took time to think about my answers.

N R S F AA

4. I didn’t read the questions thoroughly before answering.

N R S F AA

5. I marked answers just to get done quicker.

N R S F AA

6. I didn’t mind re-taking the test.

N R S F AA

7. I got better at observing my child’s behavior by taking the test
more than once.

N R S F AA

8. I skimmed the questions instead of reading them through.

N R S F AA

9. I tried to answer each question like I had answered it before.

N R S F AA

10. Sometimes I got bored and lost interest in finishing it.

N R S F AA

Debriefing Statement
Thank you for filling out this additional questionnaire and for your participation in this study.
This study has sought to learn more about how to best track changes in children and adolescents
that occur due to therapy services. This study will compare results of the three measures you
filled out in order to learn which measure is the best instrument for use in tracking these changes.
These results will ultimately provide more helpful treatment to children and adolescents because
the information provided by the best measure will help therapists adjust treatment when
necessary and help health care organizations make better decisions regarding access to therapy
services. Your time and attention has been greatly appreciated.

